<SEC-DOCUMENT>0001069258-25-000040.txt : 20250627
<SEC-HEADER>0001069258-25-000040.hdr.sgml : 20250627
<ACCEPTANCE-DATETIME>20250626182857
ACCESSION NUMBER:		0001069258-25-000040
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20250627
DATE AS OF CHANGE:		20250626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KRATOS DEFENSE & SECURITY SOLUTIONS, INC.
		CENTRAL INDEX KEY:			0001069258
		STANDARD INDUSTRIAL CLASSIFICATION:	GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				133818604
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277222
		FILM NUMBER:		251081704

	BUSINESS ADDRESS:	
		STREET 1:		10680 TREENA STREET
		STREET 2:		SUITE 600
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92131
		BUSINESS PHONE:		858-812-7300

	MAIL ADDRESS:	
		STREET 1:		10680 TREENA STREET
		STREET 2:		SUITE 600
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WIRELESS FACILITIES INC
		DATE OF NAME CHANGE:	19990817
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>kratosdefensefinal424b5.htm
<DESCRIPTION>424B5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8a6c5d41765441f4936b57d980c018da_1"></div><div style="min-height:50.4pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.083%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filed Pursuant to Rule 424(b)(5)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registration Statement No. 333-277222</font></td></tr></table></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prospectus supplement </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(to prospectus dated February 21, 2024)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">12,987,013 Shares</font></div><div style="margin-bottom:9pt;text-align:center"><img alt="kratoslogo.jpg" src="kratoslogo.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:333px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Kratos Defense &#38; Security Solutions, Inc.</font></div><div style="text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are offering 12,987,013 shares of our common stock, par value $0.001 per share, pursuant to this prospectus supplement and the accompanying prospectus. Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;KTOS.&#8221; On June 25, 2025, the last reported sale price of our common stock on the Nasdaq Global Select Market was $42.33 per share.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. Please read &#8220;Risk Factors&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of this prospectus supplement, on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of the accompanying prospectus and in the documents incorporated or deemed incorporated by reference into this prospectus supplement before investing in our common stock.</font></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per share</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Offering Price</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.50&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000,000&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting Discounts and Commissions</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,250,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds to Kratos Defense &#38; Security Solutions, Inc. before expenses</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,750,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted the underwriters an option for a period of 30 days to purchase up to an additional 1,948,052 shares of our common stock. If the underwriters exercise the option in full, the total public offering price will be $575.0 million, the total underwriting discounts and commissions payable by us will be $18.7 million, and our total proceeds, before expenses, will be $556.3 million.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters expect to deliver the common stock in book-entry form only, through the facilities of The Depository Trust Company, against payment in immediately available funds on or about&#160;June 27, 2025.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Baird</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">RBC Capital Markets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Truist Securities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Raymond James</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:27.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">B. Riley Securities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">The Benchmark Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Citizens Capital Markets</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.133%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Noble Capital Markets</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Academy Securities</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prospectus Supplement dated&#160;June 25, 2025</font></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font><br></font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-1.38pt;text-indent:18pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROSPECTUS SUPPLEMENT</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ABOUT THIS PROSPECTUS SUPPLEMENT</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TRADEMARKS, SERVICE MARKS AND COPYRIGHTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MARKET AND INDUSTRY DATA</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PROSPECTUS SUPPLEMENT SUMMARY</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RISK FACTORS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">USE OF PROCEEDS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DIVIDEND POLICY</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_34" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CERTAIN ERISA CONSIDERATIONS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">UNDERWRITING</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">VALIDITY OF SECURITIES</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_46" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXPERTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_46" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_46" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_52" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_52" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_52" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">25</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:-1.38pt;text-indent:18pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROSPECTUS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_426" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ABOUT THIS PROSPECTUS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_426" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_437" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SUMMARY</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_437" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RISK FACTORS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_464" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FORWARD-LOOKING STATEMENTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_464" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_475" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">USE OF PROCEEDS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_475" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_482" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SELLING SECURITY HOLDERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_482" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_493" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PLAN OF DISTRIBUTION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_493" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_504" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF CAPITAL STOCK</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_504" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_515" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF DEBT SECURITIES</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_515" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_522" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF WARRANTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_522" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_529" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF RIGHTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_529" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_536" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF UNITS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_536" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_543" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">LEGAL OWNERSHIP OF SECURITIES</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_543" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_550" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">LEGAL MATTERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_550" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_561" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXPERTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_561" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_572" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_572" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_583" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_583" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">32</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-i</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS SUPPLEMENT</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement and the accompanying prospectus are part of an automatic shelf registration statement that we filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) as a &#8220;well-known seasoned issuer&#8221; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), utilizing a &#8220;shelf&#8221; registration process. This document is in two parts. The first part is this prospectus supplement, including the documents incorporated by reference, which describes the specific terms of this offering. The second part, the accompanying prospectus, including the documents incorporated by reference, provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. We urge you to carefully read this prospectus supplement and the accompanying prospectus, and the documents incorporated by reference herein and therein, before buying any of the securities being offered under this prospectus supplement. This prospectus supplement may add to or update information contained in the accompanying prospectus and the documents incorporated by reference therein. To the extent that any statement we make in this prospectus supplement is inconsistent with statements made in the accompanying prospectus or any documents incorporated by reference therein that were filed before the date of this prospectus supplement, the statements made in this prospectus supplement will be deemed to modify or supersede those made in the accompanying prospectus and such documents incorporated by reference therein.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">You should rely only on the information contained in this prospectus supplement and the accompanying prospectus, or incorporated by reference herein or therein. Neither we nor the underwriters (nor any of their affiliates) have authorized anyone to provide you with different information. No underwriter, dealer, salesperson or other person, including us, has authorized anyone to give you any information or to represent anything not contained in this prospectus supplement and the accompanying prospectus. You should not rely on any unauthorized information or representation. Neither we nor the underwriters (nor any of their affiliates) take any responsibility for, or can provide any assurance as to the reliability of, any information other than the information contained in this prospectus supplement and the accompanying prospectus, or incorporated herein or therein. This prospectus supplement is an offer to sell only the securities offered hereby and only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information in this prospectus supplement and the accompanying prospectus is accurate only as of the date on the front of the applicable document and that any information we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the date of delivery of this prospectus supplement or the accompanying prospectus, or any sale of a security. Our business, financial condition, liquidity, results of operations and prospects may have changed since those dates.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise mentioned or unless the context requires otherwise, all references in this prospectus to &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;Kratos&#8221; refer to Kratos Defense &#38; Security Solutions, Inc., a Delaware corporation, and its consolidated subsidiaries.</font></div><div id="i8a6c5d41765441f4936b57d980c018da_10"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS, SERVICE MARKS AND COPYRIGHTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own or have rights to trademarks, service marks or trade names that we use in connection with the operation of our business. We also own or have the rights to copyrights that protect the content of our products. Solely for convenience, the trademarks, service marks, tradenames and copyrights referred to in this prospectus supplement are listed without the &#169;, &#174; and &#8482; symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names.</font></div><div id="i8a6c5d41765441f4936b57d980c018da_13"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET AND INDUSTRY DATA</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market data and certain other statistical information contained in the documents incorporated by reference herein is based on independent industry publications, government publications and other published independent sources. Although we believe these third-party sources are reliable as of their respective dates, we have not independently verified the accuracy or completeness of this information. The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the section entitled &#8220;Risk Factors.&#8221; These and other factors could cause results to differ materially from those expressed in these publications.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS SUPPLEMENT SUMMARY</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary is not complete and does not contain all of the information that you should consider before investing in the securities offered by this prospectus supplement. You should read this summary together with the entire prospectus supplement and the accompanying prospectus, including our consolidated financial statements, the notes to those consolidated financial statements, our Annual Report on Form 10-K for the fiscal year ended December 29, 2024 (the &#8220;Annual Report&#8221;), and the other documents that are incorporated by reference in this prospectus supplement and the accompanying prospectus, before making an investment decision. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of this prospectus supplement for a discussion of the risks involved in investing in our securities. See also &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221; on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of the accompanying prospectus and the sections entitled &#8220;Risk Factors&#8221; in the documents incorporated herein by reference.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kratos is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers&#8217; mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos&#8217; approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as the innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low cost future manufacturing which is a value add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe our probability of win is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of probability of win is greater or required investment is beyond Kratos&#8217; comfort level. Kratos&#8217; primary business areas include, virtualized ground systems for satellites and space vehicles including software for command &#38; control (C2) and telemetry, tracking and control (TT&#38;C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, command, control, communication, computing, combat, intelligence surveillance and reconnaissance (C5ISR) and microwave electronic products for missile, radar, missile defense, space, satellite, counter unmanned aircraft systems (UAS), directed energy, communication and other systems, and virtual &#38; augmented reality training systems for the warfighter. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our technology, intellectual property, proprietary products, reputation and designed-in positions on our customers&#8217; programs, platforms and systems, and our ability to rapidly develop, demonstrate and field affordable leading technology systems gives us a competitive advantage and creates a high barrier to entry into our markets. Our workforce is primarily engineering and technically oriented with a significant number of employees holding National Security clearances. Much of our work is performed at customer locations, facilities and sites, or in secure manufacturing and other facilities. Our primary end customers are National Security related agencies and large national and global commercial enterprises and entities. Our entire organization is focused on executing our strategy of being the leading technology and intellectual property based product and system company and being &#8220;first to market&#8221; in each of our industry leading core competency areas.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Corporate Information</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were initially incorporated in the state of New York in 1994 and began operations in March 1995. We reincorporated in the state of Delaware in 1998. On September&#160;12, 2007, we changed our name from Wireless Facilities,&#160;Inc. to Kratos Defense&#160;&#38; Security Solutions,&#160;Inc. Our principal executive offices are located at 1 Chisholm Trail, Suite 300, Round Rock, Texas 78681, and our telephone number is (512) 238-9840. We maintain an internet website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.kratosdefense.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have included our website address in this prospectus supplement solely as an inactive textual reference. We do not incorporate the information on, or accessible through, our website into this prospectus supplement, and you should not consider any information on or accessible through our website as part of this prospectus supplement.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-2</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE OFFERING</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kratos Defense &#38; Security Solutions, Inc.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock offered by us</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987,013 shares of our common stock (or 14,935,065 shares of our common stock if the underwriters exercise their option to purchase additional shares in full).</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock outstanding after this offering</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,430,355 shares of our common stock (or 168,378,407&#160;shares of our common stock if the underwriters exercise their option to purchase additional shares in full).</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option to purchase additional shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948,052 shares of our common stock.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of proceeds</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We expect the net proceeds from this offering will be approximately $483.8&#160;million (or $556.3&#160;million if the underwriters exercise their option to purchase additional shares in full) after deducting underwriting discounts and commissions, as described in &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Underwriting</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">,&#8221; and estimated offering expenses payable by us. We expect to use the net proceeds from this offering to fund investments and capital expenditures to scale and successfully execute on large, mission critical National Security priorities related to existing programs, recent program awards and significant high-probability pipeline opportunities, to finance important customer and program targeted acquisitions and for general corporate purposes, including pay-down of debt, and to pay fees and expenses in connection with this offering. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221;</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend policy</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We currently intend to retain any future earnings to finance the growth and development of the business and, therefore, do not anticipate paying any cash dividends in the foreseeable future. In addition, our ability to pay dividends is restricted by the terms of the agreements governing our debt. Any future determination to pay cash dividends or engage in stock buybacks will be at the discretion of our board of directors and will be dependent upon our future financial condition, results of operations and capital requirements, general business conditions and other relevant factors as determined by our board of directors. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Policy</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nasdaq Global Select Market symbol</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;KTOS&#8221;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk factors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This investment involves a high degree of risk. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of this prospectus supplement, on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of the accompanying prospectus and in the documents incorporated by reference into this prospectus supplement for a discussion of factors you should carefully consider before deciding to invest in our common stock.</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of our common stock to be outstanding immediately after the closing of this offering is based on 153,443,342 shares of common stock outstanding as of May 2, 2025 and excludes, as of that date&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">5,523,258 shares of common stock available for future grant under our 2023 Employee Stock Purchase Plan and our 2023 Equity Incentive Plan&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">4,673,654 shares of common stock issuable upon the vesting and settlement of restricted stock units.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, this prospectus supplement reflects and assumes no exercise by the underwriters of their option to purchase additional shares from us.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-3</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An investment in our common stock involves a substantial risk of loss. You should carefully consider the following risk factors and all other information contained herein as well as the information included or incorporated by reference in this prospectus supplement and the accompanying prospectus before you decide to invest in our common stock. The occurrence of any of the following risks could harm our business. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our operations. You should also refer to the other information contained in this prospectus supplement and the accompanying prospectus or incorporated by reference herein or therein, including our financial statements and the notes to those statements, as well as the information contained in our Annual Report (including the &#8220;Risk Factors&#8221; discussed under Item 1A of such report) which is incorporated by reference herein, and the information set forth under the heading &#8220;Special Note Regarding Forward-Looking Information.&#8221;</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Investments in Our Securities (in addition to risks set forth in our Annual Report)</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may allocate the net proceeds from this offering in ways that you and other stockholders may not approve.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to use the net proceeds from this offering to fund investments and capital expenditures to scale and successfully execute on large, mission critical National Security priorities related to existing programs, recent program awards and significant high-probability pipeline opportunities, to finance important customer and program targeted acquisitions and for general corporate purposes, including pay-down of debt and to pay fees and expenses in connection with this offering. In general, our management will have broad discretion in the application of the net proceeds from this offering and could spend the net proceeds in ways that do not necessarily improve our operating results or enhance the value of our common stock. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Proceeds</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price may be volatile, and your investment in our stock could suffer a decline in value.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock may fluctuate significantly, and you may not be able to resell your shares at or above the price at which you purchased your shares. Factors which could have a significant impact on the market price of our common stock include, but are not limited to, the following, most of which we cannot control&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quarterly variations in operating results&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in preference by our customers&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of new services or products or significant price reductions by us or our competitors or other actions by our competitors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the gain or loss of significant customers&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stock price performance or changes in the market valuations of our competitors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in analysts&#8217; earnings estimates or publication of research reports about our industry&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rumors or dissemination of false information&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">default on our indebtedness&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our senior management or key personnel&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pricing pressures&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in stock market prices and volumes&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">short selling of our common stock&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation and government inquiries&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general conditions in the market&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent and duration of any pandemics or other public health risks&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and&#47;or military events associated with current worldwide and regional conflicts&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">events affecting other companies that investors deem comparable to us.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other external factors may cause the market price and demand for our common stock to fluctuate substantially, which may limit or prevent investors from readily selling their shares of common stock and may otherwise negatively affect the liquidity of our common stock. Volatility in the market price of our common stock could also subject us to securities class action litigation.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of our common stock could cause the market price for our common stock to decline.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the effect, if any, that market sales of shares of our common stock or the availability of shares of our common stock for sale will have on the market price of our common stock prevailing from time to time. Sales of substantial amounts of shares of our common stock in the public market, or the perception that those sales will occur, could cause the market price of our common stock to decline or be depressed.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock issued in connection with this offering will be freely tradable without restriction or further registration under the Securities Act.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we and our directors and executive officers have agreed with the underwriters to a &#8220;lock-up&#8221;, pursuant to which neither we nor they will sell, hedge or otherwise dispose of any shares without the prior written consent of Robert W. Baird &#38; Co. Incorporated for 90 days after the date of this prospectus supplement, subject to certain exceptions. Following the expiration of the applicable lock-up period, all these shares of our common stock will also be eligible for future sale.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may issue our securities if we need to raise capital in connection with a capital expenditure, working capital requirement or acquisition. The amount of shares of our common stock issued in connection with a capital expenditure, working capital requirement or acquisition could constitute a material portion of our then-outstanding shares of common stock. Any perceived excess in the supply of our shares in the market could negatively impact our share price and any issuance of additional securities in connection with investments or acquisitions may result in additional dilution to you.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any cash dividends or buyback any Kratos stock for the foreseeable future.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not declared any cash dividends since becoming a public company. We currently intend to retain any future earnings to finance the growth and development of the business and, therefore, we do not anticipate that we will pay any cash dividends on shares of our common stock in the foreseeable future. In addition, our ability to pay dividends and buyback Kratos stock is restricted by our credit facility. Any determination to pay dividends or stock buybacks in the future will be at the discretion of our board of directors and will be dependent upon our future financial condition, results of operations and capital requirements, general business conditions and other relevant factors as determined by our board of directors. Accordingly, if you purchase shares in this offering, realization of a gain on your investment will depend on the appreciation of the price of our common stock, which may never occur. Investors seeking cash dividends in the foreseeable future should not purchase our common stock. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_31" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Policy</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and any trading volume could decline.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our securities depends in part on the research and reports that industry or financial analysts publish about us or our business. We do not influence or control the reporting of these analysts. If one or more of the analysts who do cover us downgrade or provide a negative outlook on our Company or our industry, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the stock of any of our competitors, the price of our common stock could decline. If one or more of these analysts ceases coverage of our Company, we could lose visibility in the market, which in turn could cause the price of our common stock to decline.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-6</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein contain forward-looking statements within the meaning of Section&#160;27A of the Securities Act and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed in or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our future financial performance, the growth of the market for our services, expansion plans and opportunities and statements regarding our intended uses of the proceeds of the securities offered hereby. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; the negative of such terms or other comparable terminology.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements contained in or incorporated by reference into this prospectus supplement reflect our current beliefs, expectations and projections, are based on assumptions, and are subject to known and unknown risks and uncertainties that could cause our actual results or achievements to differ materially from any future results or achievements expressed in or implied by our forward-looking statements, including the factors listed below. Many of these factors are beyond our ability to control or predict. As a result, you should not place undue reliance on forward-looking statements. The most important risks and uncertainties that could cause our actual results or achievements to differ materially from the results or achievements expressed in or implied by our forward-looking statements, include, but are not limited to&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes, cutbacks or delays in spending by the U.S. Department of Defense may occur which could cause delays or cancellations of key government contracts&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays to or the cancellation of our projects as a result of protest actions submitted by our competitors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in federal government (or other applicable) procurement laws, regulations, policies and budgets&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of government funding for the Company&#8217;s products and services due to performance, cost growth, or other factors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to import-export controls, including the imposition of tariffs, embargoes, export controls and other trade restrictions&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the escalation or continuation of armed conflict, hostilities or economic sanctions between countries or regions, including the current armed conflicts in Ukraine and in the Middle East&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government and customer priorities and requirements&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential of the current economic environment to adversely impact the Company&#8217;s business&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">currently unforeseen risks associated with any public health crisis&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to natural disasters or severe weather&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the scope or timing of our projects&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, rescheduling or cancellation of significant customer contracts and agreements, or consolidation by or the loss of key customers&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks of adverse regulatory action or litigation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the Company&#8217;s international operations&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with debt leverage&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to successfully achieve our integration, cost reduction or divestiture strategies&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to security breaches, cybersecurity attacks or other significant disruptions of our information systems&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition in the marketplace, which could reduce revenues and profit margins&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks that potential future goodwill impairments will adversely affect our operating results&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks that anticipated tax benefits will not be realized in accordance with our expectations&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks that a change in ownership of our stock could cause further limitation to the future utilization of our net operating loss carryforwards.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements contained in this prospectus supplement reflect our views and assumptions only as of the date of this prospectus supplement or as of the date of the accompanying prospectus or the documents incorporated by reference. You should not place undue reliance on forward-looking statements. Except as required by law, we assume no responsibility for updating any forward-looking statements nor do we intend to do so. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. The risks included in this section are not exhaustive. There may be other factors that could cause actual results to differ materially from those described in the forward-looking statements, including those described in the sections entitled &#8220;Risk Factors&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">S-</a><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this prospectus supplement and page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the accompanying prospectus, &#8220;Risk Factors&#8221; appearing in Item 1A of our Annual Report incorporated herein by reference, and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; appearing in Item 7 of our Annual Report incorporated herein by reference.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-8</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_28"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the net proceeds from this offering to be approximately $483.8&#160;million (or $556.3&#160;million if the underwriters exercise their option to purchase additional shares in full), after deducting underwriting discounts and commissions, as described in &#8220;Underwriting,&#8221; and estimated offering expenses payable by us. We expect to use the net proceeds from this offering to fund investments and capital expenditures to scale and successfully execute on large, mission critical National Security priorities related to existing programs, recent program awards and significant high-probability pipeline opportunities, to finance important customer and program targeted acquisitions and for general corporate purposes, including pay-down of debt and to pay fees and expenses in connection with this offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this prospectus supplement, we cannot specify with certainty all of the particular uses of the proceeds from this offering. Accordingly, we will retain broad discretion over the use of such proceeds. Pending the use of the net proceeds from this offering as described above, we intend to invest the net proceeds in short-term, investment-grade securities. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors &#8211; Risks Related to Investments in Our Securities</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may allocate the net proceeds from this offering in ways that you and other stockholders may not approve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; elsewhere in this prospectus supplement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-9</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_31"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIVIDEND POLICY</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not declared any cash dividends since becoming a public company. We currently intend to retain any future earnings to finance the growth and development of the business and, therefore, do not anticipate paying any cash dividends in the foreseeable future. In addition, our ability to pay dividends is restricted by the agreement governing our credit facility, as discussed in the section entitled &#8220;Liquidity and Capital Resources&#8221; in Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 5 of the Notes to Consolidated Financial Statements contained in our Annual Report incorporated herein by reference. Any future determination to pay cash dividends will be at the discretion of our board of directors and will be dependent upon our future financial condition, results of operations and capital requirements, general business conditions and other relevant factors as determined by our board of directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-10</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_34"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the material U.S. federal income tax considerations relevant to the purchase, ownership and disposition of our common stock by a non-U.S. holder (as defined below). This summary deals only with non-U.S. holders that acquire our common stock in this offering and hold the common stock as a capital asset within the meaning of Section&#160;1221 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) (generally, property held for investment).</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this summary, a &#8220;non-U.S. holder&#8221; means a beneficial owner of our common stock (other than an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that is not any of the following for U.S. federal income tax purposes&#58; (i)&#160;an individual citizen or resident of the U.S.&#59; (ii)&#160;a corporation (or other entity treated as a corporation) created or organized in or under the laws of the U.S., any state thereof, or the District of Columbia&#59; (iii)&#160;an estate the income of which is subject to U.S. federal income taxation regardless of its source&#59; or (iv)&#160;a trust if (1)&#160;its administration is subject to the primary supervision of a court within the U.S. and one or more U.S. persons have the authority to control all of its substantial decisions, or (2)&#160;it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is based upon provisions of the Code and regulations, rulings and judicial decisions as of the date hereof. Those authorities may be changed, perhaps retroactively, or be subject to differing interpretations, so as to result in U.S. federal income tax considerations different from those summarized below. This summary does not represent a detailed description of the U.S. federal income tax considerations to you in light of your particular circumstances. In addition, it does not address the U.S. federal income tax considerations to you if you are subject to special treatment under the U.S. federal income tax laws (including if you are a bank or other financial institution, insurance company, broker or dealer in securities, tax-exempt organization, foreign government or agency, U.S. expatriate, &#8220;controlled foreign corporation,&#8221; &#8220;passive foreign investment company,&#8221; a person who is subject to the alternative minimum tax, a person who holds or received our common stock pursuant to the exercise of any employee stock option or otherwise as compensation, or a person who holds our common stock in a straddle or as part of a hedging, conversion or constructive sale transaction). Except where noted, this summary does not address any non-income federal tax consequences, such as estate or gift tax consequences, nor does it address the Medicare tax on net investment income or any state, local, or non-U.S. tax considerations. We cannot assure you that a change in law will not alter significantly the tax considerations that we describe in this summary.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity or arrangement classified as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner will generally depend on the status of the partner and the activities of the partnership. If you are a partnership holding our common stock, or a partner in such a partnership, you should consult your tax advisors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If you are considering the purchase of our common stock, you should consult your own tax advisors concerning the particular U.S. federal tax consequences to you of the purchase, ownership and disposition of our common stock, as well as the consequences to you arising under the laws of any other taxing jurisdiction, including any state, local or foreign tax consequences.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not declared any cash dividends since becoming a public company and do not anticipate paying any cash dividends on our common stock in the foreseeable future. If we were to pay cash dividends in the future on our common stock, they would be subject to U.S. federal income tax in the manner described below.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributions on our common stock generally will constitute dividends for U.S. federal income tax purposes to the extent paid out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of current and accumulated earnings and profits will be applied against and reduce a non-U.S. holder&#8217;s tax basis in our common stock, to the extent thereof, and any excess will be treated as capital gain realized on the sale or other disposition of the common stock and subject to tax in the manner described below under &#8220;&#8212;Gain on Disposition of Common Stock.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributions paid to a non-U.S. holder of our common stock that constitute dividends under the rules described above generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty. However, dividends that are effectively connected with the conduct of a trade or business by a non-U.S. holder within the U.S. and, where an income tax treaty applies, are attributable to a U.S. permanent establishment of the non-U.S. holder, are not subject to this withholding tax, but instead are subject to U.S. federal income tax on a net income basis at applicable individual or corporate rates. Certain certification and disclosure requirements must be complied with in order for effectively connected dividends to be exempt from this withholding tax. Any such effectively connected dividends received by a foreign corporation may be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A non-U.S. holder of our common stock who is entitled to and wishes to claim the benefits of an applicable treaty rate (and avoid backup withholding as discussed below) with respect to dividends received on our common stock, generally will be required (i)&#160;to complete Internal Revenue Service (&#8220;IRS&#8221;) Form&#160;W-8BEN or W-8BEN-E (or an acceptable substitute form) and make certain certifications, under penalty of perjury, to establish its status as a non-U.S. person and its entitlement to treaty benefits or (ii)&#160;if the common stock is held through certain foreign intermediaries, to satisfy the relevant certification requirements of applicable U.S. Treasury regulations. Special certification and other requirements apply to certain non-U.S. holders that are entities rather than individuals.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A non-U.S. holder of our common stock eligible for a reduced rate of U.S. federal withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the discussions below regarding backup withholding and the Foreign Account Tax Compliance Act, or &#8220;FATCA,&#8221; for additional withholding rules that may apply to distributions.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gain on Disposition of Common Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussions below regarding backup withholding and FATCA, a non-U.S. holder generally will not be subject to U.S. federal income tax with respect to gain recognized on a sale or other disposition of our common stock unless (i)&#160;the gain is effectively connected with a trade or business of the non-U.S. holder within the U.S. and, where an income tax treaty applies, is attributable to a U.S. permanent establishment of the non-U.S. holder, (ii)&#160;in the case of a non-U.S. holder who is an individual, such holder is present in the U.S. for 183 or more days in the taxable year of the sale or other disposition and certain other conditions are met, or (iii)&#160;subject to certain exceptions, we are or have been a &#8220;U.S. real property holding corporation&#8221; for U.S. federal income tax purposes and certain other conditions are met.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of a non-U.S. holder described in subsection&#160;(i) above, any net gain derived from the disposition generally will be subject to U.S. federal income tax under graduated U.S. federal income tax rates in generally the same manner as if the non-U.S. holder were a United States person as defined under the Code, unless an applicable income tax treaty provides otherwise. Additionally, a non-U.S. holder that is a corporation may be subject to a branch profits tax equal to 30% of its effectively connected earnings and profits attributable to such gain (or, if an income tax treaty applies, at such lower rate as may be specified by the treaty on its gains attributable to its U.S. permanent establishment), subject to adjustments. Except as otherwise provided by an applicable income tax treaty, an individual non-U.S. holder described in subsection&#160;(ii) above will be subject to a 30% tax on any gain derived from the disposition, which may be offset by certain U.S. source capital losses. With respect to subsection&#160;(iii) above, we believe we have not been and are not currently, and do not anticipate becoming, a &#8220;U.S. real property holding corporation&#8221; for U.S. federal income tax purposes.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Reporting and Backup Withholding</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payors must report annually to the IRS and to each non-U.S. holder the amount of distributions paid to such holder and the tax withheld (if any) with respect to such distributions, regardless of whether withholding was required. Copies of the information returns reporting such distributions and any withholding may also be made available to the tax authorities in the country in which the non-U.S. holder resides under the provisions of an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable income tax treaty. In addition, distributions paid to a non-U.S. holder may be subject to backup withholding unless applicable certification requirements are met.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of the proceeds of a sale of our common stock within the U.S. or conducted through certain U.S. related financial intermediaries is subject to information reporting and, depending upon the circumstances, backup withholding unless the non-U.S. holder certifies under penalties of perjury that it is not a U.S. person (and the payor does not have actual knowledge or reason to know that the holder is a U.S. person) or the holder otherwise establishes an exemption.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a non-U.S. holder&#8217;s U.S. federal income tax liability provided the required information is timely furnished to the IRS.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Account Tax Compliance Act</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislation commonly referred to as FATCA generally imposes a 30% U.S. federal withholding tax on certain types of payments made to (i)&#160;a &#8220;foreign financial institution&#8221; (as specifically defined in the legislation), whether such foreign financial institution is the beneficial owner or an intermediary, unless such foreign financial institution agrees to verify, report and disclose its U.S. &#8220;account&#8221; holders (as specifically defined in the legislation) and meets certain other specified requirements, or (ii)&#160;a non-financial foreign entity, whether such non-financial foreign entity is the beneficial owner or an intermediary, unless such entity provides a certification that the beneficial owner of the payment does not have any substantial U.S. owners or provides the name, address and taxpayer identification number of each such substantial U.S. owner and certain other specified requirements are met. An intergovernmental agreement between the United States and an applicable foreign country may modify the FATCA requirements. In addition, in certain cases, the relevant foreign financial institution or non-financial foreign entity may qualify for an exemption from, or be deemed to be in compliance with, these rules. Under the applicable U.S. Treasury regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of our common stock, proposed Treasury regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury regulations until final Treasury regulations are issued.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors are urged to consult with their own tax advisors regarding the possible application of these rules to their investment in our common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-13</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN ERISA CONSIDERATIONS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of certain considerations associated with the purchase of our common stock, or any interest therein by employee benefit plans that are subject to Title I of the U.S. Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), plans, individual retirement accounts and other arrangements that are subject to Section&#160;4975 of the Code or provisions under any U.S. or non-U.S. federal, state, local or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively, &#8220;Similar Laws&#8221;), and entities whose underlying assets are considered to include &#8220;plan assets&#8221; of any such plan, account or arrangement (each, a &#8220;Plan&#8221;).</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Fiduciary Matters</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ERISA and the Code impose certain duties on persons who are fiduciaries of a Plan subject to Title I of ERISA or Section&#160;4975 of the Code (a &#8220;Covered Plan&#8221;) and prohibit certain transactions involving the assets of a Covered Plan and its fiduciaries or other interested parties. Under ERISA and the Code, any person who exercises any discretionary authority or control over the administration of a Covered Plan or the management or disposition of the assets of a Covered Plan, or who renders investment advice for a fee or other compensation to a Covered Plan, is generally considered to be a fiduciary of the Covered Plan.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In considering an investment in our common stock, or any interest therein, using a portion of the assets of any Plan, a fiduciary should determine whether the investment is in accordance with the documents and instruments governing the Plan and the applicable provisions of ERISA, the Code or any Similar Law relating to a fiduciary&#8217;s duties to the Plan including, without limitation, the prudence, diversification, delegation of control, conflicts of interest and prohibited transaction provisions of ERISA, the Code and any other applicable Similar Laws. A fiduciary of a Plan should also consider the Plan&#8217;s particular circumstances and all of the facts and circumstances of the investment, including, but not limited to, the matters discussed above under &#8220;Risk Factors,&#8221; in determining whether an investment in our common stock, or any interest therein, satisfies these requirements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan fiduciaries should consider the fact that none of the issuer or the issuer&#8217;s affiliates (the &#8220;Transaction Parties&#8221;) is acting, or will act, as a fiduciary to any Plan with respect to the decision to purchase our common stock, or any interest therein, in connection with the initial offer and sale pursuant to this prospectus supplement. The Transaction Parties are not undertaking to provide impartial investment advice or advice based on any particular investment need, or to give advice in a fiduciary capacity, with respect to such decision to purchase our common stock, or any interest therein.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prohibited Transaction Issues</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;406 of ERISA and Section&#160;4975 of the Code prohibit Covered Plans from engaging in specified transactions involving plan assets with persons or entities who are &#8220;parties in interest,&#8221; within the meaning of ERISA, or &#8220;disqualified persons,&#8221; within the meaning of Section&#160;4975 of the Code, unless an exemption is available. A party in interest or disqualified person who engaged in a non-exempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code. In addition, the fiduciary of the Covered Plan that engages in such a non-exempt prohibited transaction may be subject to penalties and liabilities under ERISA and the Code. The acquisition and&#47;or holding of our common stock, or any interest therein, by a Covered Plan with respect to which is the Transactions Parties are considered a party in interest or a disqualified person may constitute or result in a direct or indirect prohibited transaction under Section&#160;406 of ERISA and&#47;or Section&#160;4975 of the Code, unless the investment is acquired and is held in accordance with an applicable statutory, class or individual prohibited transaction exemption. In this regard, the U.S. Department of Labor has issued prohibited transaction class exemptions, or &#8220;PTCEs,&#8221; that may apply to the acquisition and holding of our common stock, or any interest therein. These class exemptions include, without limitation, PTCE 84-14 respecting transactions determined by independent qualified professional asset managers, PTCE 90-1 respecting insurance company pooled separate accounts, PTCE 91-38 respecting bank collective investment funds, PTCE 95-60 respecting life insurance company general accounts and PTCE 96-23 respecting transactions determined by in-house asset managers, although there can be no assurance that all of the conditions of any such exemptions will be satisfied.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the foregoing, our common stock, or any interest therein, should not be purchased or held by any person investing &#8220;plan assets&#8221; of any Plan, unless such purchase and holding will not constitute a non-exempt prohibited transaction under ERISA and the Code or similar violation of any applicable Similar Laws.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Representation</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, by acceptance of our common stock, or any interest therein, each purchaser and subsequent transferee of our common stock, or any interest therein, will be deemed to have represented and warranted that either (i)&#160;no portion of the assets used by such purchaser or transferee to acquire and hold our common stock, or any interest therein, constitutes assets of any Plan or (ii)&#160;the purchase and holding of our common stock, or any interest therein, by such purchaser or transferee will not constitute a non-exempt prohibited transaction under Section&#160;406 of ERISA or Section&#160;4975 of the Code or similar violation under any applicable Similar Laws.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing discussion is general in nature and is not intended to be all inclusive. Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is particularly important that fiduciaries, or other persons considering purchasing our common stock, or any interest therein, on behalf of, or with the assets of, any Plan, consult with their counsel regarding the potential applicability of ERISA, Section&#160;4975 of the Code and any Similar Laws to such investment and whether an exemption would be applicable to the purchase and holding of our common stock, or any interest therein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-15</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDERWRITING</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are offering the shares of common stock described in this prospectus through a number of underwriters. Robert W. Baird &#38; Co. Incorporated is acting as the representative of the underwriters. We have entered into an underwriting agreement with the representative of the underwriters for itself and the other underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of shares of common stock listed next to its name in the following table&#58;</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. Baird &#38; Co. Incorporated</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946,930&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RBC Capital Markets, LLC</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433,941&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Securities, Inc.</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433,941&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond James &#38; Associates, Inc.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433,941&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B. Riley Securities, Inc.</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,610&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Benchmark Company, Inc.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,610&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citizens JMP Securities, LLC.</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,640&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noble Capital Markets, Inc.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,640&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academy Securities, Inc.</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,760&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987,013&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters are committed to purchase all the shares of common stock offered by us if they purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters propose to offer the shares of common stock directly to the public at the initial public offering price set forth on the cover page of this prospectus supplement and to certain dealers at that price less a concession not in excess of $0.75075&#160;per share. Any such dealers may resell shares to certain other brokers or dealers at a discount of up to $0.50050&#160;per share from the initial public offering price. After the initial public offering of the shares, the offering price and other selling terms may be changed by the underwriters. The offering of the shares by the underwriters is subject to receipt and acceptance and subject to the underwriters&#8217; right to reject any order in whole or in part.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters have an option to buy up to 1,948,052 additional shares of our common stock from us to cover sales of shares by the underwriters which exceed the number of shares specified in the table above. The underwriters have 30 days from the date of this prospectus supplement to exercise this option to purchase additional shares. If any shares are purchased with this option to purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters will offer the additional shares on the same terms as those on which the shares are being offered.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriting discounts and commissions are equal to the public offering price per share of common stock less the amount paid by the underwriters to us per share of common stock. The underwriting discounts and commissions are $1.25125&#160;per share. The following table shows the per share and total underwriting discounts and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters&#8217; option to purchase additional shares.</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Without underwriters&#8217; option exercise</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">With full underwriters&#8217; option exercise</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per Share</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25125&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25125&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,250,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,687,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the total expenses of this offering, including registration, filing and listing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $500,000.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prospectus in electronic format may be made available on the websites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representative to underwriters and selling group members that may make Internet distributions on the same basis as other allocations.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed, subject to specified exceptions, that we will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise dispose of, directly or indirectly, or file with the SEC a registration statement under the Securities Act relating to, any shares of our common stock or securities convertible into or exchangeable or exercisable for any shares of our common stock, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, or (ii) enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case without the prior written consent of Robert W. Baird &#38; Co. Incorporated for a period of 90 days after the date of this prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, with limited exceptions, for a period of 90 days after the date of this prospectus, may not, without the prior written consent of Robert W. Baird &#38; Co. Incorporated, (i) offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of, or publicly disclose the intention to make any offer, sale, pledge or disposition of, any shares of our common stock or securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, shares of our common stock or any such securities which may be deemed to be beneficially owned by such officers and directors in accordance with the rules and regulations promulgated under the Exchange Act (such shares or securities, the (&#8220;Beneficially Owned Shares&#8221;)), (ii) enter into any swap, hedge or other agreement or arrangement that transfers in whole or in part, the economic risk of ownership of any Beneficially Owned Shares, our common stock or securities convertible into or exercisable or exchangeable for our common stock, or (iii) engage in any short selling of any Beneficially Owned Shares, our common stock or securities convertible into or exercisable or exchangeable for our common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Robert W. Baird &#38; Co. Incorporated, in its sole discretion and at any time or from time to time before the termination of the 90 day restricted period, without public notice, may release all or any portion of the securities subject to lock-up agreements. There are no existing agreements between the underwriters and us providing consent to the sale of shares prior to the expiration of the lock-up period. Sales of a substantial number of such shares upon expiration of the lock-up and market stand-off agreements, the perception that such sales may occur, or early release of these agreements, could cause our market price to fall or make it more difficult for you to sell your common stock at a time and price that you deem appropriate.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#8220;KTOS.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling shares of common stock in the open market for the purpose of preventing or retarding a decline in the market price of the common stock while this offering is in progress. These stabilizing transactions may include making short sales of the common stock, which involves the sale by the underwriters of a greater number of shares of common stock than they are required to purchase in this offering, and purchasing shares of common stock on the open market to cover positions created by short sales. Short sales may be &#8220;covered&#8221; shorts, which are short positions in an amount not greater than the underwriters&#8217; option to purchase additional shares referred to above, or may be &#8220;naked&#8221; shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriters will consider, among other things, the price of shares available for purchase in the open market compared to the price at which the underwriters may purchase shares through the option to purchase additional shares. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a naked short position, they will purchase shares in the open market to cover the position.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters have advised us that, pursuant to Regulation M of the Securities Act, they may also engage in other activities that stabilize, maintain or otherwise affect the price of the common stock, including the imposition of penalty bids. This means that if the representative of the underwriters purchase common stock in the open market in stabilizing transactions or to cover short sales, the representative can require the underwriters that sold those shares as part of this offering to repay the underwriting discount received by them.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These activities may have the effect of raising or maintaining the market price of the common stock or preventing or retarding a decline in the market price of the common stock, and, as a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities, they may discontinue them at any time. The underwriters may carry out these transactions on Nasdaq, in the over-the-counter market or otherwise.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with this offering certain of the underwriters (and selling group members) may engage in passive market making transactions in our common stock on Nasdaq prior to the pricing and completion of this offering. Passive market making consists of displaying bids on Nasdaq no higher than the bid prices of independent market makers and making purchases at prices no higher than these independent bids and effected in response to order flow. Net purchases by a passive market maker on each day are generally limited to a specified percentage of the passive market maker&#8217;s average daily trading volume in the common stock during a specified period and must be discontinued when such limit is reached. Passive market making may cause the price of our common stock to be higher than the price that otherwise would exist in the open market in the absence of these transactions. If passive market making is commenced, it may be discontinued at any time.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Canada</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions, and Ongoing Registrant Obligations. Any resale of the securities must be made in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory of these rights or consult with a legal advisor.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dubai</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority (the &#8220;DFSA&#8221;). This prospectus supplement is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this prospectus supplement. The shares to which this prospectus supplement relates may be illiquid and&#47;or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not understand the contents of this prospectus supplement you should consult an authorized financial advisor.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">European Economic Area</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of this prospectus supplement, the accompanying prospectus or any related free writing prospectus is a prospectus for the purposes of Regulation (EU) 2017&#47;1129, as amended (the &#8220;Prospectus Regulation&#8221;). This prospectus supplement, the accompanying prospectus and any related free writing prospectus have been prepared on the basis that any offer of shares of our common stock in any Member State of the European Economic Area (the &#8220;EEA&#8221;) (each, a &#8220;Relevant State&#8221;) will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of shares of our common stock. Accordingly, any person making or intending to make an offer in any Relevant State of shares of our common stock which are the subject of the offering contemplated in this prospectus supplement, the accompanying prospectus and any related free writing prospectus may only do so in circumstances in which no obligation arises for the Company or any of the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Regulation in relation to such offer. None of the Company or the underwriters have authorized, nor do they authorize, the making of any offer of shares of our common stock in the EEA in circumstances in which an obligation arises for the Company or the underwriters to publish a prospectus for such offer.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to each Relevant State, no shares of our common stock have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares of our common stock which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that the shares of our common stock may be offered to the public in that Relevant State at any time&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">in any other circumstances falling within Article 1(4) of the Prospectus Regulation,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that no such offer of the shares of our common stock shall require the Company or the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Regulation.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the shares of our common stock in any Relevant State means the communication in any form and by means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of our common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United Kingdom</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of this prospectus supplement, the accompanying prospectus or any related free writing prospectus is a prospectus for the purposes of Regulation (EU) 2017&#47;1129, as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended (the &#8220;EUWA&#8221;) (the &#8220;UK Prospectus Regulation&#8221;). This prospectus supplement, the accompanying prospectus and any related free writing prospectus have been prepared on the basis that any offer of shares of our common stock in the United Kingdom will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to publish a prospectus for offers of shares of our common stock. Accordingly, any person making or intending to make an offer in the United Kingdom of shares of our common stock which are the subject of the offering contemplated in this prospectus supplement, the accompanying prospectus and any related free writing prospectus may only do so in circumstances in which no obligation arises for the Company or any of the underwriters to publish a prospectus pursuant to Section 85 of the United Kingdom&#8217;s Financial Services and Markets Act 2000, as amended (the &#8220;FSMA&#8221;) in relation to such offer. None of the Company or the underwriters have authorized, nor do they authorize, the making of any offer of shares of our common stock in the United Kingdom in circumstances in which an obligation arises for the Company or the underwriters to publish a prospectus for such offer. No shares of our common stock have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in relation to the shares of our common stock which has been approved by the Financial Conduct Authority, except that the shares of our common stock may be offered to the public in the United Kingdom at any time&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">in any other circumstances falling within Section 86 of the FSMA,</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that no such offer of the shares of our common stock shall require the Company or the underwriters to publish a prospectus pursuant to Section 85 of the FSMA.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the shares of our common stock in the United Kingdom means the communication in any form and by means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of our common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The communication of this prospectus supplement, the accompanying prospectus, any related free writing prospectus and any other document or materials relating to the issue of the shares of our common stock offered hereby is not being made, and such documents and&#47;or materials have not been approved, by an authorized person for the purposes of section 21 of the FSMA. Accordingly, this prospectus supplement, the accompanying prospectus, any related free writing prospectus and such other documents and&#47;or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom. This prospectus supplement, the accompanying prospectus, any related free writing prospectus and such other documents and&#47;or materials are for distribution only to persons who (i) have professional experience in matters relating to investments and who fall within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the &#8220;Financial Promotion Order&#8221;)), (ii) fall within Article 49(2)(a) to (d) of the Financial Promotion Order, (iii) are outside the United Kingdom or (iv) are other persons to whom it may otherwise lawfully be made under the Financial Promotion Order (all such persons together being referred to as &#8220;relevant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">persons&#8221;). This prospectus supplement, the accompanying prospectus, any related free writing prospectus and such other documents and&#47;or materials are directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this prospectus supplement, the accompanying prospectus, any related free writing prospectus and any other document or materials relate will be engaged in only with relevant persons. Any person in the United Kingdom that is not a relevant person should not act or rely on this prospectus supplement, the accompanying prospectus, any related free writing prospectus or any other documents and&#47;or materials relating to the issue of the shares of our common stock offered hereby or any of their contents.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) in connection with the issue or sale of the shares of our common stock may only be communicated or caused to be communicated in circumstances in which Section 21(1) of the FSMA does not apply to the Company.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All applicable provisions of the FSMA must be complied with in respect to anything done by any person in relation to the shares of common our stock in, from or otherwise involving the United Kingdom.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hong Kong</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock have not and will not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong) (&#8220;Companies (Winding Up and Miscellaneous Provisions) Ordinance&#8221;) or Securities and Futures Ordinance, or (ii) to &#8220;professional investors&#8221; within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (&#8220;Securities and Futures Ordinance&#8221;) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance, and no advertisement, invitation or document relating to the shares have been or will be issued or have been or will be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made thereunder. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Japan</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for re-offering or resale, directly or indirectly, in Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph, &#8220;Japanese Person&#8221; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Singapore</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement, the accompanying prospectus, and any related free writing prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus supplement, the accompanying prospectus, any related free writing prospectus, and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act 2001 (2020 Revised Edition) of Singapore (the &#8220;SFA&#8221;)) under Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, in accordance with the conditions specified in Section 275 of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the shares are subscribed or purchased under Section 275 of the SFA by a relevant person which is&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section 275 of the SFA except&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(c)(ii) of the SFA&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">where no consideration is or will be given for the transfer&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">where the transfer is by operation of law&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as specified in Section 276(7) of the SFA&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018 of Singapore.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solely for the purposes of its obligations pursuant to Section 309B of the SFA and the Securities and Futures (Capital Markets Products) Regulations 2018 (the &#8220;CMP Regulations 2018&#8221;), we have determined, and hereby notify all relevant persons (as defined in the CMP Regulations 2018), that the shares are prescribed capital markets products (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in Monetary Authority of Singapore Notice SFA04-N12&#58; Notice on the Sale of Investment Products and Monetary Authority of Singapore Notice FAA-N16&#58; Notice of Recommendations of Investment Products).</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Switzerland</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement, the accompanying prospectus, any related free writing prospectus, and accompanying prospectus are not intended to constitute an offer or solicitation to purchase or invest in the common stock. The common stock may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act (&#8220;FinSA&#8221;) and will not be listed on the SIX Swiss Exchange (&#8220;SIX&#8221;) or on any other stock exchange or regulated trading venue (exchange or multilateral trading facility) in Switzerland. This document does not constitute a prospectus within the meaning of, and has been prepared without regard to, the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading venue (exchange or multilateral trading facility) in Switzerland. Neither this document nor any other offering or marketing material relating to the common stock constitutes a prospectus pursuant to the FinSA, and neither this document nor any other offering or marketing material relating to the common stock or the offering may be publicly distributed or otherwise made publicly available in Switzerland.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither this document nor any other offering or marketing material relating to the offering, the Company, or the common stock have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of common stock will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of common stock has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#8220;CISA&#8221;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Relationships</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and non-financial activities and services. Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to the issuer and to persons and entities with relationships with the issuer, for which they received or will receive customary fees and expenses. In particular, Truist Bank, an affiliate of Truist Securities, Inc., acts as the administrative agent and is a lender under our credit facility and affiliates of certain of the other underwriters are lenders under our credit facility.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of their various business activities, the underwriters and their respective affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments and actively traded securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate to assets, securities and&#47;or instruments of the issuer (directly, as collateral securing other obligations or otherwise) and&#47;or persons and entities with relationships with the issuer. The underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and&#47;or publish or express independent research views in respect of such assets, securities or instruments and may at any time hold, or recommend to clients that they should acquire, long and&#47;or short positions in such assets, securities and instruments.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-23</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_43"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALIDITY OF SECURITIES</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the common stock being offered by this prospectus supplement will be passed upon for us by our counsel, Sheppard, Mullin, Richter &#38; Hampton LLP, Menlo Park, California. Certain legal matters in connection with this offering will be passed upon for the underwriters by Simpson Thacher &#38; Bartlett LLP, New York, New York.</font></div><div id="i8a6c5d41765441f4936b57d980c018da_46"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company incorporated by reference in this prospectus supplement, and the effectiveness of the Company&#8217;s internal control over financial reporting, have been audited by Deloitte &#38; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are incorporated by reference in reliance upon the report of such firm, given their authority as experts in accounting and auditing.</font></div><div id="i8a6c5d41765441f4936b57d980c018da_49"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file annual, quarterly and special reports, proxy statements and other information with the SEC. The SEC maintains an Internet website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including Kratos. You may also access our reports and proxy statements free of charge at our Internet website, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.kratosdefense.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The information contained in, or that can be accessed through, our website is not part of this prospectus supplement. The prospectus included in this filing is part of a registration statement filed by us with the SEC. The full registration statement can be obtained from the SEC, as indicated above, or from us.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-24</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_52"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC allows us to incorporate by reference the information we file with it, which means that we can disclose important information to you by referring you to another document that we have filed separately with the SEC. The information incorporated by reference is considered to be a part of this prospectus supplement and the accompanying prospectus. We hereby incorporate by reference the following information or documents into this prospectus supplement&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000106925825000008/ktos-20241229.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the fiscal year ended December 29, 2024 filed with the SEC on February 26, 2025&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the portions of our </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000106925825000018/ktos-20250402.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Definitive Proxy Statement</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the SEC on April 4, 2025, incorporated by reference into the Annual Report on Form 10-K for the fiscal year ended December 29, 2024&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Quarterly Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000106925825000028/ktos-20250330.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-Q</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the quarterly period ended March 30, 2025 filed with the SEC on May 7, 2025&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Current Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000106925825000031/ktos-20250514.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 8-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the SEC on May 19, 2025&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the description of our common stock contained in our Registration Statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000107299399000158/0001072993-99-000158.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 8-A</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (File No. 000-27231), filed under Section 12(g) of the Exchange Act on September 3, 1999, including any subsequent amendment or report filed for the purpose of amending such description, including </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000106925820000006/ktos20191229ex-44.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 4.4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Annual Report on Form 10-K for the fiscal year ended December 29, 2019 (filed with the SEC on February 24, 2020).</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this prospectus supplement or the accompanying prospectus or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incorporate by reference any future filings (other than information in current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, until we sell all of the securities offered by this prospectus supplement. Information in such future filings updates and supplements the information provided in this prospectus supplement. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon written or oral request, we will provide to you, without charge, a copy of any or all of the documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus but not delivered with the prospectus, including exhibits which are specifically incorporated by reference into such documents. Requests should be directed to&#58; Kratos Defense &#38; Security Solutions, Inc., Attention&#58; Investor Relations, 1 Chisholm Trail, Suite 300, Round Rock, TX 78681, telephone (512) 238-9840.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-25</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_404"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS</font></div><div style="margin-bottom:20pt;text-align:center"><img alt="kratoslogoa.jpg" src="kratoslogoa.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:274px"></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Kratos Defense &#38; Security Solutions, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrants</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rights</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Units</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time offer to sell any combination of the securities described in this prospectus, either individually or in units, in one or more offerings. In addition, certain selling security holders to be identified in supplements to this prospectus may offer and sell these securities from time to time.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus provides a general description of the securities we may offer. Each time we sell securities, we will provide specific terms of the securities offered in a supplement to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference herein or therein before you invest in any securities. This prospectus may not be used to consummate a sale of securities unless accompanied by the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#8220;KTOS.&#8221; The applicable prospectus supplement will contain information, where applicable, as to any other listing on The Nasdaq Global Select Market or any securities market or other exchange of the securities, if any, covered by the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in our securities involves risks. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">4</a></font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities may be offered directly by us or by any selling security holder from time to time, through agents designated by us or to or through underwriters, brokers or dealers. We will provide specific information about any selling security holders in one or more supplements to this prospectus. For additional information on the methods of sale, you should refer to the section entitled &#8220;Plan of Distribution&#8221; in this prospectus. If any underwriters are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of such underwriters and any applicable commissions or discounts will be set forth in a prospectus supplement or a related free writing prospectus. The price to the public of such securities and the net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement or a related free writing prospectus.</font></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:18.472%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The date of this prospectus is February 21, 2024</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font><br></font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_414"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_426" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ABOUT THIS PROSPECTUS</a></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_426" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_437" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SUMMARY</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_437" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RISK FACTORS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_464" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FORWARD-LOOKING STATEMENTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_464" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_475" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">USE OF PROCEEDS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_475" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_482" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SELLING SECURITY HOLDERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_482" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_493" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PLAN OF DISTRIBUTION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_493" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_504" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF CAPITAL STOCK</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_504" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_515" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF DEBT SECURITIES</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_515" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_522" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF WARRANTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_522" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_529" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF RIGHTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_529" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_536" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF UNITS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_536" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_543" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">LEGAL OWNERSHIP OF SECURITIES</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_543" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_550" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">LEGAL MATTERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_550" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_561" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXPERTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_561" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_572" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_572" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_583" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_583" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">32</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_426"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This prospectus is a part of an automatic shelf registration statement that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), as a &#8220;well-known seasoned issuer&#8221; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), utilizing a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may sell any combination of the securities described in this prospectus in one or more offerings. In addition, selling security holders to be named in a prospectus supplement may sell certain of our securities from time to time. This prospectus provides you with a general description of the securities we may offer. Each time we or any selling security holder offers to sell securities under this shelf registration statement, we or the selling security holder will provide a prospectus supplement that will contain specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change information contained in this prospectus or in any documents that we have incorporated by reference into this prospectus. To the extent that any statement that we make in a prospectus supplement is inconsistent with statements made in this prospectus, the statement made in this prospectus will be deemed modified or superseded by those made in the prospectus supplement. You should read this prospectus, any applicable prospectus supplement and any related free writing prospectus, together with the information incorporated herein by reference as described under the heading &#8220;Where You Can Find Additional Information&#8221; and &#8220;Incorporation of Certain Information by Reference.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">You should rely only on the information that we have provided or incorporated by reference in this prospectus, any applicable prospectus supplement and any related free writing prospectus that we may authorize to be provided to you. You should assume that the information in this prospectus is accurate only as of the date of this prospectus, that any information in any accompanying prospectus supplement is accurate only as of the date of such accompanying prospectus supplement,.and that any information included in another document incorporated by reference herein is accurate only as of the date of such document We have not authorized any broker, dealer, salesperson or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus, any applicable prospectus supplement or any related free writing prospectus that we may authorize to be provided to you. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus, the accompanying prospectus supplement or related free writing prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This prospectus, any accompanying prospectus supplement, and any related free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor do this prospectus, any accompanying prospectus supplement, or any related free writing prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any information we have incorporated by reference therein is correct on any date subsequent to the date set forth on the front of the document incorporated by reference, even though this prospectus, any applicable prospectus supplement or any related free writing prospectus is delivered or the applicable securities are sold on a later date. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This prospectus, any accompanying prospectus supplement, and any related free writing prospectus may contain estimates and other information concerning our target markets that are based on industry publications, surveys and forecasts. This information involves a number of assumptions and limitations and you are cautioned not to give undue weight to this information. Please read the section of this prospectus entitled &#8220;Cautionary Statement Regarding Forward-Looking Statements.&#8221; The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described under the heading &#8220;Risk Factors&#8221; contained in the applicable prospectus supplement and any related free writing prospectus, and in our most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC. These and other factors could cause actual results to differ materially from those expressed in such publications, surveys and forecasts. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &#8220;Where You Can Find Additional Information.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_437"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights selected information from this prospectus and the documents incorporated herein by reference and does not contain all of the information that you need to consider in making your investment decision. You should carefully read this entire prospectus, including the risks of investing in our securities discussed under &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8a6c5d41765441f4936b57d980c018da_453" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of this prospectus, the information incorporated herein by reference, including the information in such documents under the heading &#8220;Risk Factors&#8221; and our financial statements, and the exhibits to the registration statement of which this prospectus is a part. All references in this prospectus to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Kratos,&#8221; the &#8220;Company&#8221; and similar designations refer to Kratos Defense &#38; Security Solutions, Inc. and its consolidated subsidiaries, unless otherwise indicated or as the context otherwise requires.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kratos is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers&#8217; mission critical needs and requirements. At Kratos, affordability is a technology, and we utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos&#8217; approach reducing cost, schedule and risk, and enabling us to be first to market with cost effective solutions. Kratos is known as the innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low-cost future manufacturing and as a competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kratos&#8217; primary business areas include, virtualized ground systems for satellites and space vehicles including software for command &#38; control (C2) and telemetry, tracking and control (TT&#38;C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual &#38; augmented reality training systems for the warfighter.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our workforce is primarily engineering and technically oriented with a significant number of employees holding national security clearances. Much of our work is performed at customer locations, or in a secure manufacturing facility and other facilities. Our primary end customers are defense and national security related agencies, communications and other global enterprises. Our entire organization is focused on executing our strategy of being the leading technology and intellectual property based product and system company and being &#8220;first to market&#8221; in each of our industry leading core competency areas.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Corporate Information</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were initially incorporated in the state of New York in 1994, commenced operations in 1995 and were reincorporated in Delaware in 1998. On September 12, 2007, we changed our name from Wireless Facilities, Inc. to Kratos Defense &#38; Security Solutions, Inc. Our executive offices are located at 1 Chisholm Trail, Suite 300, Round Rock, TX 78681, and our telephone number is (512) 238-9840 . We maintain an Internet website at www.kratosdefense.com. We have included our website address in this prospectus solely as an inactive textual reference. We do not incorporate the information on, or accessible through, our website into this prospectus, and you should not consider any information on or accessible through our website as part of this prospectus. Our common&#160;stock trades on The Nasdaq Global Select Market under the trading symbol &#8220;KTOS&#8221;.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities We May Offer</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may offer shares of our common stock and preferred stock, various series of debt securities and warrants or rights to purchase any of such securities, either individually or in units, from time to time under this prospectus, together with any applicable prospectus supplement and related free writing prospectus, at prices and on terms to be determined by market conditions at the time of offering. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities, we will provide a prospectus </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">designation or classification&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">aggregate principal amount or aggregate offering price&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maturity, if applicable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">original issue discount, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rates and times of payment of interest or dividends, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redemption, conversion, exchange or sinking fund terms, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conversion prices, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ranking&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictive covenants, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">voting or other rights, if any&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">important U.S. federal income tax considerations.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change information contained in this prospectus or in documents we have incorporated by reference. However, no prospectus supplement or free writing prospectus will offer a security that is not registered and described in this prospectus at the time of the effectiveness of the registration statement of which this prospectus is a part.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIS PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF SECURITIES UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities may be offered directly by us or by any selling security holder from time to time, through agents designated by us or to or through underwriters, brokers or dealers. We will provide specific information about any selling security holders in one or more supplements to this prospectus. We, and our underwriters or agents, reserve the right to accept or reject all or part of any proposed purchase of securities. If we do offer securities through underwriters or agents, we will include in the applicable prospectus supplement&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the names of those agents, underwriters, brokers or dealers&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">applicable fees, discounts and commissions to be paid to them&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">details regarding options to purchase additional securities, if any&#59; and </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the net proceeds to us.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_453"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risks and uncertainties described under the section captioned &#8220;Risk Factors&#8221; contained in our most recent Annual Report on Form 10-K, our most recent Quarterly Report on Form 10-Q and other filings we make with the SEC from time to time, which are incorporated by reference herein in their entirety, together with the other information in this prospectus, the accompanying prospectus supplement, any free writing prospectus, and in the documents incorporated by reference in this prospectus. The risks described in our most recent Annual Report on Form 10-K, any subsequently filed Quarterly Reports on Form 10-Q and the other filings we make with the SEC incorporated by reference herein are not the only ones facing the Company. Additional risks and uncertainties may also impair our business operations. If any of the risks described in this prospectus, any accompanying prospectus supplement, any related free writing prospectus, our most recent Annual Report on Form 10-K, any subsequently filed Quarterly Reports on Form 10-Q and the other filings incorporated by reference herein occurs, our business, financial condition, results of operations and future growth prospects could be harmed. In these circumstances, the market price of our common stock or other securities could decline, and you may lose all or part of your investment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_464"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus and the documents incorporated herein by reference contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements are based on our management&#8217;s current beliefs, expectations and assumptions about future events, conditions and results and on information currently available to us. Discussions containing these forward-looking statements may be found, among other places, in the Sections entitled &#8220;Business,&#8221; &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; incorporated by reference from our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All statements, other than statements of historical fact, included or incorporated herein regarding our strategy, future operations, financial position, future revenues, projected costs, plans, prospects and objectives are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; the negative of such terms or other comparable terminology. Important risks and uncertainties that could cause our actual results or achievements to differ materially from the results or achievements reflected in our forward-looking statements include, but are not limited to&#58; changes, cutbacks or delays in spending by the U.S. Department of Defense may occur which could cause delays or cancellations of key government contracts&#59; delays to or the cancellation of our projects as a result of protest actions submitted by our competitors&#59; changes in federal government (or other applicable) procurement laws, regulations, policies and budgets&#59; the availability of government funding for the Company&#8217;s products and services due to performance, cost growth, or other factors&#59; changes in government and customer priorities and requirements&#59; the potential of the current economic environment to adversely impact our business&#59; currently unforeseen risks associated with COVID-19 or any other public health crisis&#59; risks related to natural disasters or severe weather&#59; changes in the scope or timing of our projects&#59; the timing, rescheduling or cancellation of significant customer contracts and agreements, or consolidation by or the loss of key customers&#59; risks of adverse regulatory action or litigation&#59; risks associated with debt leverage&#59; failure to successfully achieve our integration, cost reduction or divestiture strategies&#59; risks related to security breaches, cybersecurity attacks or other significant disruptions of our information systems&#59; and competition in the marketplace, which could reduce revenues and profit margins.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such statements are based on currently available operating, financial and competitive information and are subject to various risks, uncertainties and assumptions that could cause actual results to differ materially from those anticipated or implied in our forward-looking statements due to a number of factors including, but not limited to, those set forth above or included or incorporated herein, those set forth under the section entitled &#8220;Risk Factors&#8221; in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto filed with the SEC. Given these risks, uncertainties and other factors, many of which are beyond our control, you should not place undue reliance on these forward-looking statements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to revise any forward-looking statements to reflect events or developments occurring after the date of this prospectus, even if new information becomes available in the future.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_475"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described in any applicable prospectus supplement and in any free writing prospectuses in connection with a specific offering, we currently intend to use the net proceeds from the sale of the securities offered hereby for general corporate purposes, including, among other things, working capital requirements and potential repayment of indebtedness that may be outstanding at the time of any offering under this prospectus. We may also use a portion of the net proceeds from the sale of the securities offered hereby to acquire or invest in businesses, services and technologies that are complementary to our own, although we have no present commitments or agreements to do so. Accordingly, we will retain broad discretion over the use of such proceeds. Pending these uses, we intend to invest the net proceeds in investment-grade, interest-bearing securities. We will not receive any of the proceeds from sales of securities by selling security holders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_482"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELLING SECURITY HOLDERS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the registration statement of which this prospectus forms a part is used by selling security holders for the resale of any securities registered thereunder pursuant to a registration rights agreement to be entered into by us with such selling security holders or otherwise, information about such selling security holders, their beneficial ownership of our securities and their relationship with us will be set forth in a prospectus supplement, any free writing prospectus or in other filings we make with the SEC under the Exchange Act that are incorporated by reference into the registration statement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_493"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN OF DISTRIBUTION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, or the applicable selling security holders, may sell the securities being offered hereby in one or more of the following ways from time to time&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through agents to the public or to investors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to underwriters, brokers or dealers for resale to the public or to investors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in &#8220;at the market offerings&#8221; within the meaning of Rule 415(a)(4) under the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">directly to investors&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through a combination of any of these methods of sale&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through any other methods described in a prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each time we offer and sell securities, we will provide a prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) that will describe the terms of the offering of the securities, including, to the extent applicable&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the name or names of any agents or underwriters, brokers or dealers and the amount of shares underwritten or purchased by each of them&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the purchase price of the securities being offered and the proceeds we will receive from the sale&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any over-allotment options under which underwriters may purchase additional securities from us&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any agency fees or underwriting discounts and other items constituting agents&#8217; or underwriters&#8217; compensation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any initial public offering price&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any discounts or concessions allowed or reallowed or paid to brokers or dealers&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any securities exchanges or markets on which such securities may be listed.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may designate agents who agree to use their reasonable efforts to solicit purchases of our securities for the period of their appointment or to sell our securities on a continuing basis. We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay to the agent in the applicable prospectus supplement. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we use underwriters for a sale of securities, the underwriters will acquire the securities for their own account. The underwriters may resell the securities in one or more transactions, including negotiated transactions, at a fixed public offering price, at varying prices determined at the time of sale, at prices related to prevailing market prices or at negotiated prices. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all of the securities offered by the prospectus supplement, other than securities covered by any over-allotment or other option. We may change from time to time any initial public offering price and any discounts or concessions the underwriters allow or reallow or pay to brokers or dealers. We may use underwriters with whom we have a material relationship. We will describe the nature of any such relationship in any prospectus supplement naming any such underwriter. Only underwriters we name in the applicable prospectus supplement are underwriters of the securities offered by such prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also sell securities directly to one or more purchasers without using underwriters or agents. Underwriters, brokers, dealers and agents that participate in the distribution of the securities may be underwriters as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defined in the Securities Act, and any discounts or commissions they receive from us and any profit on their resale of the securities may be treated as underwriting discounts and commissions under the Securities Act. We will identify in the applicable prospectus supplement any underwriters, brokers, dealers or agents and will describe their compensation. We may have agreements with the underwriters, brokers, dealers and agents to indemnify them against specified civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which they may be required to make in respect thereof. Underwriters, brokers, dealers and agents may engage in transactions with or perform services for us in the ordinary course of their businesses.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and&#47;or the selling security holders, if applicable, may authorize underwriters, brokers, dealers or agents to solicit offers by certain purchasers to purchase the securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts will be subject only to those conditions set forth in the applicable prospectus supplement, and the applicable prospectus supplement will set forth any commissions we pay for solicitation of these contracts. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise specified in the applicable prospectus supplement, each class or series of securities will be a new issue with no established trading market, other than our common stock, which is listed on The Nasdaq Global Select Market. We may elect to list any other class or series of securities on any exchange or market, but we are not obligated to do so. It is possible that one or more underwriters may make a market in a class or series of securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the exchanges or markets for any of the securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any underwriter may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. Overallotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Syndicate-covering or other short covering transactions involve purchases of the securities in the open market after the distribution is completed to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of these activities at any time.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any underwriters who are qualified market makers on The Nasdaq Global Select Market may engage in passive market making transactions in the securities on The Nasdaq Global Select Market in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the securities. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security. If all independent bids are lowered below the passive market maker&#8217;s bid, however, the passive market maker&#8217;s bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Underwriters and their affiliates may be customers of, engage in transactions with or perform services for us or our affiliates in the ordinary course of business.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in two business days, unless the parties to any such trade expressly agree otherwise or the securities are sold by us to an underwriter in a firm commitment underwritten offering. The applicable prospectus supplement may provide that the original issue date for your securities may be more than two scheduled business days after the trade date for your securities. Accordingly, in such a case, if you wish to trade securities on any date prior to the second business day before the original issue date for your securities, you will be required, by virtue of the fact that your securities initially are expected to settle in more than two scheduled business days after the trade date for your securities, to make alternative settlement arrangements to prevent a failed settlement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_504"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description of our capital stock, together with any additional information we include in any applicable prospectus supplements or any free writing prospectuses that we may authorize to be delivered to you, summarizes the material terms and provisions of our capital stock that we may offer under this prospectus. While the terms we have summarized below will apply generally to any future capital stock that we may offer, we will describe the particular terms of any class or series of these securities in more detail in the applicable prospectus supplement or free writing prospectus. This description is only a summary. For the complete terms of our capital stock, please refer to our amended and restated certificate of incorporation (as amended, our &#8220;Certificate of Incorporation&#8221;) and our second amended and restated bylaws (as amended, our &#8220;Bylaws&#8221;), that are incorporated by reference into the registration statement, of which this prospectus forms a part. The terms of these securities may also be affected by the Delaware General Corporation Law (the &#8220;DGCL&#8221;). The summary below and any summary contained in any prospectus supplement or free writing prospectus are qualified in their entirety by reference to our Certificate of Incorporation and our Bylaws.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 195,000,000 shares of common stock, par value $0.001 per share, of which 129,997,441 shares were issued and outstanding as of February 9, 2024. The holders of common stock possess exclusive voting rights in us, except to the extent our board of directors specifies voting power with respect to any other class of securities issued in the future. Each holder of our common stock is entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors. Stockholders do not have any right to cumulate votes in the election of directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may be granted to the holders of preferred stock, each holder of our common stock is entitled to share ratably in distributions to stockholders and to receive ratably such dividends as may be declared by our board of directors out of funds legally available therefor. In the event of our liquidation, dissolution or winding up, the holders of our common stock will be entitled to receive, after payment of all of our debts and liabilities and of all sums to which holders of any preferred stock may be entitled, the distribution of any of our remaining assets. Holders of our common stock have no conversion, exchange, sinking fund, redemption or appraisal rights (other than as may be determined by our board of directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the outstanding shares of our common stock are, and the shares of common stock issued upon the conversion of any securities convertible into our common stock will be, fully paid and non-assessable. The shares of common stock offered by this prospectus or upon the conversion of any preferred stock or debt securities or exercise of any warrants offered pursuant to this prospectus, when issued and paid for, will also be, fully paid and non-assessable.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#8220;KTOS.&#8221;</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Undesignated Preferred Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 5,000,000 shares of preferred stock, par value $0.001 per share, none of which were issued and outstanding as of February 9, 2024. Our board of directors is authorized to classify or reclassify any unissued portion of our authorized shares of preferred stock to provide for the issuance of shares of other classes or series, including preferred stock in one or more series. We may issue preferred stock from time to time in one or more classes or series, with the exact terms of each class or series established by our board of directors. Without seeking stockholder approval, our board of directors may issue preferred stock with voting and other rights that could adversely affect the voting power of the holders of our common stock. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of the common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences, privileges and restrictions of the preferred stock of each series will be fixed by the certificate of designation relating to each series. A prospectus supplement relating to each series will specify the terms of the preferred stock, including, but not limited to&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the distinctive designation and the maximum number of shares in the series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms on which dividends, if any, will be paid&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the voting rights, if any, on the shares of the series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and conditions, if any, on which the shares of the series shall be convertible into, or exchangeable for, shares of any other class or classes of capital stock&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms on which the shares may be redeemed, if at all&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the liquidation preference, if any&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any or all other preferences, rights, restrictions, including restrictions on transferability, and qualifications of shares of the series.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of preferred stock may delay, deter or prevent a change in control.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will describe the specific terms of a particular series of preferred stock in the prospectus supplement relating to that series. The description of preferred stock above and the description of the terms of a particular series of preferred stock in the prospectus supplement are not complete. You should refer to the applicable certificate of designation for complete information. The applicable prospectus supplement will contain a description of U.S. federal income tax consequences relating to the preferred stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Possible Anti-Takeover Effects of Delaware Law and our Charter Documents</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions of the DGCL and our Certificate of Incorporation and Bylaws could make it more difficult to acquire us by means of a tender offer, a proxy contest or otherwise, or to remove incumbent officers and directors. These provisions, summarized below, are expected to discourage certain types of coercive takeover practices and takeover bids that our board of directors may consider inadequate and to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging takeover or acquisition proposals because, among other things, negotiation of these proposals could result in an improvement of their terms.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware Anti-Takeover Statute</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the DGCL, an anti-takeover statute. In general, Section 203 of the DGCL prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years following the time the person became an interested stockholder, unless the business combination or the acquisition of shares that resulted in a stockholder becoming an interested stockholder is approved in a prescribed manner. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns (or within three years prior to the determination of interested stockholder status did own) 15% or more of the applicable corporation&#8217;s voting stock. The existence of this provision would be expected to have an anti-takeover effect with respect to transactions not approved in advance by our board of directors, including discouraging attempts that might result in a premium over the market price for the shares of common stock held by our stockholders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Election and Removal of Directors</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is elected annually by all holders of our capital stock. To be eligible for election or appointment to the board of directors, an individual must meet certain director qualification requirements set forth in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our Bylaws. At a special meeting of stockholders, directors may be removed without cause by the affirmative vote of the holders of at least a majority of the outstanding shares entitled to vote on such removal.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of the holders of at least 66 2&#47;3 % of the voting power of all of the then-outstanding shares of our voting stock, voting together as a single class, is required to, among other things, alter, amend or repeal certain provisions of our Certificate of Incorporation, including those related to the election and removal of the board of directors, amendment of our Bylaws and Certificate of Incorporation, restrictions against stockholder actions by written consent and the indemnification of officers and directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws, may only be amended (or new bylaws adopted) by the board of directors or the affirmative vote of the holders of at least 66 2&#47;3 % of the voting power of all of the then-outstanding shares of our voting stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Size of Board and Vacancies</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our Certificate of Incorporation and our Bylaws, our board of directors has the exclusive right to fix the size of the board and to fill any vacancies resulting from death, resignation, disqualification or removal as well as any newly created directorships arising from an increase in the size of the board of directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Stockholder Meetings</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that only a majority of the total number of directors then in office may call a special meeting of the stockholders, and any business conducted at any special meeting must have been properly brought before the meeting. To be properly brought before a meeting, business must be specified in the notice of meeting (or any supplement thereto) given by or at the direction of our board of directors, otherwise properly brought before the meeting by or at the direction of our board of directors, or otherwise properly brought before the meeting by a stockholder, but, in the case of a special meeting, if and only if the notice of the meeting provides for business to be brought before the meeting by a stockholder.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Action by Unanimous Written Consent</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation expressly eliminates the right of our stockholders to act by written consent. Stockholder action must take place at the annual or a special meeting of our stockholders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements for Advance Notification of Stockholder Nominations and Proposals</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws establish advance notice procedures with respect to stockholder proposals and nomination of candidates for election as directors other than nominations made by or at the direction of our board of directors or a committee of our board of directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No Cumulative Voting</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DGCL provides that stockholders are denied the right to cumulate votes in the election of directors unless a company's certificate of incorporation provides otherwise. Our Certificate of Incorporation does not provide for cumulative voting.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Undesignated Preferred Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authority that will be possessed by our board of directors to issue preferred stock could potentially be used to discourage attempts by third parties to obtain control of the Company through a merger, tender offer, proxy contest or otherwise by making such attempts more difficult or more costly. Our board of directors may issue preferred stock with voting rights or conversion rights that, if exercised, could adversely affect the voting power of the holders of our common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Authorized but Unissued Shares</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized but unissued shares of common stock and preferred stock will be available for future issuance without stockholder approval. We may use additional shares for a variety of purposes, including future public offerings to raise additional capital, to fund acquisitions and as employee compensation. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is EQ Shareowner Services. Its address is 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120 and its telephone number is (800) 468-9716. The transfer agent for any series of preferred stock that we may offer under this prospectus will be named and described in the prospectus supplement for that series.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_515"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF DEBT SECURITIES</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description, together with the additional information we include in any applicable prospectus supplements or free writing prospectuses, summarizes the material terms and provisions of the debt securities that we may offer under this prospectus. We may issue an unlimited amount of debt securities, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized below will apply generally to any future debt securities we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement or free writing prospectus. The terms of any debt securities we offer under a prospectus supplement may differ from the terms we describe below. Unless the context requires otherwise, whenever we refer to the &#8220;indentures,&#8221; we also are referring to any supplemental indentures that specify the terms of a particular series of debt securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will issue any senior debt securities under the senior indenture and any supplemental indentures that we will enter into with the trustee named in the senior indenture. We will issue any subordinated debt securities under the subordinated indenture and any supplemental indentures that we will enter into with the trustee named in the subordinated indenture. We have filed forms of these documents as exhibits to the registration statement, of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with the SEC.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures will be qualified under the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). We use the term &#8220;trustee&#8221; to refer to either the trustee under the senior indenture or the trustee under the subordinated indenture, as applicable.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summaries of material provisions of the senior debt securities, the subordinated debt securities and the applicable indentures are subject to, and qualified in their entirety by reference to, all of the provisions of the indenture and any supplemental indentures applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well as the complete indentures and supplemental indentures that contain the terms of the debt securities. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the manner provided in an officers&#8217; certificate or by a supplemental indenture. Debt securities may be issued in separate series without limitation as to aggregate principal amount. We may specify a maximum aggregate principal amount for the debt securities of any series. We will describe in the applicable prospectus supplement the terms of the series of debt securities being offered, including&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the title&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the principal amount being offered, and if a series, the total amount authorized and the total amount outstanding&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any limit on the amount that may be issued&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether or not we will issue the series of debt securities in global form, and, if so, the terms and who the depositary will be&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the maturity date&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a U.S. person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the annual interest rate, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether or not the debt securities will be secured or unsecured, and the terms of any secured debt&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms of the subordination of any series of subordinated debt&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the place where payments will be payable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on transfer, sale or other assignment, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our right, if any, to defer payment of interest and the maximum length of any such deferral period&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date, if any, after which, and the price at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provisions for a sinking fund purchase or other analogous fund, if any, including the date, if any, on which, and the price at which we are obligated, pursuant thereto or otherwise, to redeem, or at the holder&#8217;s option, to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the applicable indenture will restrict our ability or the ability of our subsidiaries to&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional indebtedness&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue additional securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or make distributions in respect of our capital stock or the capital stock of our subsidiaries&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redeem capital stock&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place restrictions on our subsidiaries&#8217; ability to pay dividends, make distributions or transfer assets&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make investments or other restricted payments&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell, transfer or otherwise dispose of assets&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into sale-leaseback transactions&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in transactions with stockholders or affiliates&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue or sell stock of our subsidiaries&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effect a consolidation or merger&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">information describing any book-entry features&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the applicability of the provisions in the indenture on discharge&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the debt securities are to be offered at a price such that they will be deemed to be offered at an &#8220;original issue discount&#8221; as defined in paragraph (a) of Section 1273 of the Internal Revenue Code of 1986, as amended&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the denominations in which we will issue the series of debt securities, if other than denominations of $2,000 and any integral multiple of $1,000 in excess thereof&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, including any additional events of default or covenants provided with respect to the debt securities, and any terms that may be required by us or advisable under applicable laws or regulations.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. federal income tax consequences related to the debt securities, including tax consequences applicable to debt securities sold at an original issue discount, will be described in the applicable prospectus supplement. In addition, U.S. federal income tax or other consequences applicable to any debt securities which are denominated in a currency or currency unit other than U.S. dollars may be described in the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion or Exchange Rights</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will set forth in the applicable prospectus supplement the terms under which a series of debt securities may be convertible into or exchangeable for our common stock, our preferred stock or other securities (including securities of a third party). We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our common stock, our preferred stock or other securities (including securities of a third party) that the holders of the series of debt securities receive would be subject to adjustment.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation, Merger or Sale</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indentures will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially all of our assets. However, any successor to or acquiror of such assets must assume all of our obligations under the indentures or the debt securities, as appropriate. If the debt securities are convertible into or exchangeable for our other securities or securities of third parties, the person with whom we consolidate or merge or to whom we sell all of our property must make provisions for the conversion of the debt securities into securities that the holders of the debt securities would have received if they had converted the debt securities before the consolidation, merger or sale.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Events of Default under an Indenture</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indentures with respect to any series of debt securities that we may issue&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if we fail to pay interest when due and payable and our failure continues for 30 days&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if we fail to pay the principal, premium or sinking fund payment, if any, when due and payable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if we fail to observe or perform any other covenant contained in the debt securities or the indentures, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we receive notice from the trustee or we and the trustee receive notice from the holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if specified events of bankruptcy, insolvency or reorganization occur.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will describe in each applicable prospectus supplement any additional events of default relating to the relevant series of debt securities. If an event of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above, the applicable trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice to us in writing, and to the applicable trustee if notice is given by such holders, may declare the unpaid principal, premium, if any, and accrued interest, if any, due and payable immediately. If an event of default arises due to the occurrence of certain specified bankruptcy, insolvency or reorganization events, the unpaid principal, premium, if any, and accrued interest, if any, of each issue of debt securities then outstanding shall be due and payable without any notice or other action on the part of the trustee or any holder of such debt securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any such waiver shall cure the default or event of default.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the applicable indenture, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the trustee reasonable indemnity or security satisfactory to it against any loss, liability or expense. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities of that series, provided that&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the direction so given by the holder is not in conflict with any law or the applicable indenture&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subject to its duties under the Trust Indenture Act, the trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures provide that if an event of default has occurred and is continuing, the trustee will be required in the exercise of its powers to use the degree of care that a prudent person would use in the conduct of its own affairs. The trustee, however, may refuse to follow any direction that conflicts with law or the indenture, or that the trustee determines is unduly prejudicial to the rights of any other holder of the relevant series of debt securities, or that would involve the trustee in personal liability. Prior to taking any action under the indentures, the trustee will be entitled to indemnification against all costs, expenses and liabilities that would be incurred by taking or not taking such action.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A holder of the debt securities of any series will have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek other remedies only if&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the holder has given written notice to the trustee of a continuing event of default with respect to that series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made a written request and such holders have offered reasonable indemnity to the trustee or security satisfactory to it against any loss, liability or expense to be incurred in compliance with instituting the proceeding as trustee&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions within 60 days after the notice, request and offer.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will periodically file statements with the trustee regarding our compliance with specified covenants in the indentures.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures provide that if a default occurs and is continuing and is actually known to a responsible officer of the trustee, the trustee must mail to each holder notice of the default within 45 days after it occurs, unless such default has been cured. Except in the case of a default in the payment of principal or premium of, or interest on, any debt security or certain other defaults specified in the applicable indenture, the trustee shall be protected in withholding such notice if and so long as the board of directors, the executive committee or another committee of directors, or responsible officers of the trustee, in good faith determine that withholding notice is in the best interests of holders of the relevant series of debt securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Modification of Indenture&#59; Waiver</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the applicable indenture for any series of debt securities that we may issue, we and the trustee may modify or amend an indenture without the consent of any holders of the applicable debt securities with respect to the following specific matters&#58;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to fix any ambiguity, defect or inconsistency in the indenture&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to comply with the provisions described above under &#8220;&#8212;Consolidation, Merger or Sale&#59;&#8221;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to add to, delete from or revise the conditions, limitations and restrictions on the authorized amount, terms or purposes of issue, authentication and delivery of debt securities, as set forth in such indenture&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to provide for the issuance of, and establish the form and terms and conditions of, the debt securities of any series as provided above under &#8220;&#8212;General,&#8221; to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to evidence and provide for the acceptance of appointment hereunder by a successor trustee or other agent&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to comply with the applicable procedures of the applicable depositary&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to provide for uncertificated debt securities in addition to or in place of certificated debt securities and to make all appropriate changes for such purpose&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to secure debt securities of any series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to add such new covenants, restrictions, conditions or provisions for the protection of the holders, and to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default or to surrender any right or power conferred to us in the indenture&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to change anything that does not materially adversely affect the interests of any holder of debt securities of any series in any material respect&#59; provided that any amendment made solely to conform the provisions of the indenture to the corresponding description of the debt securities contained in the applicable prospectus or prospectus supplement shall be deemed not to adversely affect the interests of the holders of such debt securities&#59; provided further, that in connection with any such amendment we will provide the trustee with an officers&#8217; certificate certifying that such amendment will not adversely affect the rights or interests of the holders of such debt securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the indentures, the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee may only make the following changes to the applicable indenture with the consent of each holder of any outstanding debt securities affected&#58;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">extending the fixed maturity of the series of debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption of any debt securities&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver of such indenture&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changing any of our obligations to pay additional amounts&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the amount of principal of an original issue discount security or any other note payable upon acceleration of the maturity thereof&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changing the currency in which any note or any premium or interest is payable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairing the right to enforce any payment on or with respect to any note&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adversely changing the right to convert or exchange such series of debt securities, including decreasing the conversion rate or increasing the conversion price of, such debt securities, if applicable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of the subordinated indenture, modifying the subordination provisions in a manner adverse to the holders of the subordinated debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the debt securities are secured, changing the terms and conditions pursuant to which the debt securities are secured in a manner adverse to the holders of the secured debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the requirements contained in the applicable indenture for quorum or voting&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changing any of our obligations to maintain an office or agency in the places and for the purposes required by the applicable indenture&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">modifying any of the above provisions described in this paragraph.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discharge</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each indenture provides that, subject to the terms of such indenture and any limitation otherwise provided in the prospectus supplement applicable to a particular series of debt securities, we may elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified obligations, including obligations to&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">register the transfer or exchange of debt securities of such series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">replace stolen, lost or mutilated debt securities of such series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain paying agents&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hold monies for payment in trust&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recover excess money held by the trustee&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensate and indemnify the trustee&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appoint any successor trustee.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to exercise our rights to be discharged, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, and any premium and interest on, the debt securities of the series on the dates payments are due.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form, Exchange and Transfer</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will issue the debt securities of each series only in fully registered form without coupons and, unless we otherwise specify in the applicable prospectus supplement, in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. The indentures provide that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company or another depositary named by us and identified in a prospectus supplement with respect to that series. See &#8220;Legal Ownership of Securities&#8221; below for a further description of the terms relating to any book-entry securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the option of the holder, subject to the terms of the indentures and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any series can exchange such debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the indentures and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of debt securities may present such debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, or the indenture governing the terms of such debt securities, we will impose no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we elect to redeem debt securities of any series, we will not be required to&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Concerning the Trustee</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable trustee, other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically set forth in the applicable indenture and is under no obligation to exercise any of the powers given it by the indentures at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur. However, upon an event of default under an indenture, the trustee must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment and Paying Agents</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest payment.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement, we will designate the corporate trust office of the trustee in the City of New York as our sole paying agent for payments with respect to debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governing Law</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures and the debt securities will be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ranking of Debt Securities</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The subordinated debt securities will be unsecured and will be subordinate and junior in priority of payment to certain of our other indebtedness to the extent described in the applicable prospectus supplement. The subordinated indenture does not limit the amount of subordinated debt securities that we may issue. It also does not limit us from issuing any other secured or unsecured debt.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The senior debt securities will be unsecured and will rank equally in right of payment with all our other senior unsecured debt. The senior indenture does not limit the amount of senior debt securities that we may issue. It also does not limit us from issuing any other secured or unsecured debt.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_522"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF WARRANTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description, together with the additional information we may include in any applicable prospectus supplements and any applicable free writing prospectuses, summarizes the material terms and provisions of the warrants that we may offer under this prospectus, which may consist of warrants to purchase common stock, preferred stock or debt securities and may be issued in one or more series. Warrants may be offered independently or together with common stock, preferred stock or debt securities offered by any prospectus supplement, and may be attached to or separate from those securities. While the terms we have summarized below will apply generally to any warrants that we may offer under this prospectus, we will describe the particular terms of any series of warrants that we may offer in more detail in the applicable prospectus supplement and any applicable free writing prospectus. The terms of any warrants offered under a prospectus supplement may differ from the terms described below. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer a security that is not registered and described in this prospectus at the time of its effectiveness.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will issue the warrants under a warrant agreement that we will enter into with a warrant agent to be selected by us. The warrant agent will act solely as an agent of ours in connection with the warrants and will not act as an agent for the holders or beneficial owners of the warrants. We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from a Current Report on Form 8-K that we file with the SEC, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular series of warrants we are offering before the issuance of the related series of warrants. The following summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to a particular series of warrants. We urge you to read the applicable prospectus supplement and any applicable free writing prospectus related to the particular series of warrants that we sell under this prospectus, as well as the complete warrant agreements and warrant certificates that contain the terms of the warrants.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will describe in the applicable prospectus supplement the terms relating to a series of warrants, including&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the offering price and aggregate number of warrants offered&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the currency for which the warrants may be purchased&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the date on and after which the warrants and the related securities will be separately transferable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of warrants to purchase common stock or preferred stock, the number of shares of common&#160;stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms of any rights to redeem or call the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dates on which the right to exercise the warrants will commence and expire&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the manner in which the warrant agreements and warrants may be modified&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the material United States federal income tax consequences of holding or exercising the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms of the securities issuable upon exercise of the warrants&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium, if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise of Warrants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth on the reverse side of the warrant certificate and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enforceability of Rights by Holders of Warrants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each warrant agent will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_529"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF RIGHTS</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue rights to purchase common stock, preferred stock or the other securities described in this prospectus. This prospectus, any accompanying prospectus supplement, and any applicable free writing prospectus will contain the material terms and conditions for each right. The accompanying prospectus supplement may add, update or change the terms and conditions of the rights as described in this prospectus.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will describe in the applicable prospectus supplement the terms and conditions of the issue of rights being offered, the rights agreement relating to the rights and the rights certificates representing the rights, including, as applicable&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the title of the rights&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date of determining the stockholders entitled to the rights distribution&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the title, aggregate number of shares of common stock, preferred stock or other securities purchasable upon exercise of the rights&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the exercise price&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the currencies in which the rights are being offered&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the aggregate number of rights issued&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date, if any, on and after which the rights will be separately transferable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date on which the right to exercise the rights will commence and the date on which the right will expire&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise of Rights</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each right will entitle the holder of rights to purchase for cash the principal amount of shares of common stock, preferred stock or other securities at the exercise price provided in the applicable prospectus supplement. Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus supplement. After the close of business on the expiration date, all unexercised rights will be void.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may exercise rights as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the shares of common&#160;stock, preferred stock, or other securities purchasable upon exercise of the rights. If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters, brokers or dealers or through a combination of such methods, including pursuant to standby underwriting arrangements, as described in the applicable prospectus supplement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_536"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF UNITS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description, together with the additional information we may include in any applicable prospectus supplements and any applicable free writing prospectuses, summarizes the material terms and provisions of the units that we may offer under this prospectus. While the terms we have summarized below will apply generally to any units that we may offer under this prospectus, we will describe the particular terms of any series of units in more detail in the applicable prospectus supplement. The terms of any units offered under a prospectus supplement may differ from the terms described below. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer a security that is not registered and described in this prospectus at the time of its effectiveness.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from a Current Report on Form 8-K that we file with the SEC, the form of unit agreement that describes the terms of the series of units we are offering, and any supplemental agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement and any supplemental agreements applicable to a particular series of units. We urge you to read the applicable prospectus supplements related to the particular series of units that we sell under this prospectus, as well as the complete unit agreement and any supplemental agreements that contain the terms of the units.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue units comprised of one or more debt securities, shares of common stock, shares of preferred stock, warrants or rights in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will describe in the applicable prospectus supplement the terms of the series of units, including&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any provisions of the governing unit agreement that differ from those described in this prospectus&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions described in this section, as well as those described under &#8220;Description of Capital Stock,&#8221; &#8220;Description of Debt Securities,&#8221; &#8220;Description of Warrants&#8221; and &#8220;Description of Rights&#8221; will apply to each unit and to any common stock, preferred stock, debt security, warrant or right included in each unit, respectively.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance in Series</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue units in such amounts and in any number of distinct series as we determine.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enforceability of Rights by Holders of Units</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any unit. A single bank or trust company may act as unit agent for more than one series of units. A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or any security included in such unit, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the consent of the related unit agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any security included in the unit.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the unit agents and any of their agents may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any purpose and as the person entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary. See &#8220;Legal Ownership of Securities.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_543"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL OWNERSHIP OF SECURITIES</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can issue securities in registered form or in the form of one or more global securities. We describe global securities in greater detail below. We refer to those persons who have securities registered in their own names on the books that we or any applicable trustee, depositary, warrant agent or other agent maintain for this purpose as the &#8220;holders&#8221; of those securities. These persons are the legal holders of the securities. We refer to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their own names, as &#8220;indirect holders&#8221; of those securities. As we discuss below, indirect holders are not legal holders, and investors in securities issued in book-entry form or in street name will be indirect holders.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Book-Entry Holders</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue securities in book-entry form only, as will be specified in the applicable prospectus supplement. This means securities may be represented by one or more global securities registered in the name of a financial institution that holds them as depositary on behalf of other financial institutions that participate in the depositary&#8217;s book-entry system. These participating institutions, which are referred to as participants, in turn, hold beneficial interests in the securities on behalf of themselves or their customers.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only the person in whose name a security is registered is recognized as the holder of that security. Global securities will be registered in the name of the depositary. Consequently, for global securities, we will recognize only the depositary as the holder of the securities, and we will make all payments on the securities to the depositary. The depositary passes along the payments it receives to its participants, which in turn pass the payments along to their customers who are the beneficial owners. The depositary and its participants do so under agreements they have made with one another or with their customers&#59; they are not obligated to do so under the terms of the securities we may offer.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, investors in a global security will not own securities directly. Instead, they will own beneficial interests in a global security, through a bank, broker or other financial institution that participates in the depositary&#8217;s book-entry system or holds an interest through a participant. As long as the securities are issued in global form, investors will be indirect holders, and not legal holders, of the securities.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Street Name Holders</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate a global security or issue securities that are not issued in global form. In these cases, investors may choose to hold their securities in their own names or in &#8220;street name.&#8221; Securities held by an investor in street name would be registered in the name of a bank, broker or other financial institution that the investor chooses, and the investor would hold only a beneficial interest in those securities through an account he or she maintains at that institution.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For securities held in street name, we or any applicable trustee or depositary will recognize only the intermediary banks, brokers and other financial institutions in whose names the securities are registered as the holders of those securities, and we or any such trustee or depositary will make all payments on those securities to them. These institutions pass along the payments they receive to their customers who are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities in street name will be indirect holders, not legal holders, of those securities.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Holders</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations, as well as the obligations of any applicable trustee, agent or third party employed by us or a trustee or any agents, run only to the legal holders of the securities. We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means. This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are issuing the securities only in global form.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, once we make a payment or give a notice to the holder, we have no further responsibility for the payment or notice even if that holder is required, under agreements with its participants or customers or by law, to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pass it along to the indirect holders but does not do so. Similarly, we may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our obligation to comply with a particular provision of an indenture, or for other purposes. In such an event, we would seek approval only from the legal holders, and not the indirect holders, of the securities. Whether and how the legal holders contact the indirect holders is up to the legal holders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we refer to &#8220;you&#8221; in this prospectus, we mean those who invest in the securities being offered by this prospectus, whether they are the holders or only indirect holders of those securities. When we refer to &#8220;your securities&#8221; in this prospectus, we mean the securities in which you will hold a direct or indirect interest.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Considerations for Indirect Holders</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you hold securities through a bank, broker or other financial institution, either in book-entry form because the securities are represented by one or more global securities or in street name, you should check with your own institution to find out&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">how it handles securities payments and notices&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether it imposes fees or charges&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">how it would handle a request for the holders&#8217; consent, if ever required&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether and how you can instruct it to send you securities registered in your own name so you can be a legal holder, if that is permitted in the future&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">how it would exercise rights under the securities if there were a default or other event triggering the need for holders to act to protect their interests&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the securities are in book-entry form, how the depositary&#8217;s rules and procedures will affect these matters.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global Securities</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A global security is a security that represents one or any other number of individual securities held by a depositary. Generally, all securities represented by the same global securities will have the same terms. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each security issued in book-entry form will be represented by a global security that we issue to, deposit with and register in the name of a financial institution or its nominee that we select. The financial institution that we select for this purpose is called the depositary. Unless we specify otherwise in the applicable prospectus supplement, The Depository Trust Company (&#8220;DTC&#8221;) will be the depositary for all securities we issue in book-entry form.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A global security may not be transferred to or registered in the name of anyone other than the depositary, its nominee or a successor depositary, unless special termination situations arise. We describe those situations below under &#8220;&#8212;Special Situations When A Global Security Will Be Terminated.&#8221; As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and legal holder of all securities represented by a global security, and investors will be permitted to own only beneficial interests in such global security. Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with the depositary or with another institution that does. Thus, an investor whose security is represented by a global security will not be a legal holder of the security, but only an indirect holder of a beneficial interest in the global security.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the prospectus supplement for a particular security indicates that the security will be issued as a global security, then the security will be represented by a global security at all times unless and until the global security is terminated. If termination occurs, we may issue the securities through another book-entry clearing system or decide that the securities may no longer be held through any book-entry clearing system.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Considerations For Global Securities</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an indirect holder, an investor&#8217;s rights relating to a global security will be governed by the account rules of the investor&#8217;s financial institution and of the depositary, as well as general laws relating to securities transfers. We do not recognize an indirect holder as a holder of securities and instead deal only with the depositary that holds the global security.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are issued only as global securities, an investor should be aware of the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an investor cannot cause the securities to be registered in his or her name, and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations we describe below&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an investor will be an indirect holder and must look to his or her own bank or broker for payments on the securities and protection of his or her legal rights relating to the securities, as we describe above&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an investor may not be able to sell interests in the securities to some insurance companies and to other institutions that are required by law to own their securities in non-book-entry form&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an investor may not be able to pledge his or her interest in the global security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the depositary&#8217;s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor&#8217;s interest in the global security. We and any applicable trustee have no responsibility for any aspect of the depositary&#8217;s actions or for its records of ownership interests in the global security. We and the trustee also do not supervise the depositary in any way&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the depositary may, and we understand that DTC will, require that those who purchase and sell interests in the global security within its book-entry system use immediately available funds, and your broker or bank may require you to do so as well&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial institutions that participate in the depositary&#8217;s book-entry system, and through which an investor holds its interest in the global security, may also have their own policies affecting payments, notices and other matters relating to the securities. There may be more than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Situations When A Global Security Will Be Terminated</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a few special situations described below, a global security will terminate and interests in it will be exchanged for physical certificates representing those interests. After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in securities transferred to their own names, so that they will be direct holders. We have described the rights of holders and street name investors above.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we provide otherwise in the applicable prospectus supplement, a global security will terminate when the following special situations occur&#58;</font></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary for that global security and we do not appoint another institution to act as depositary within 90 days&#59;</font></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if we notify any applicable trustee that we wish to terminate that global security&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if an event of default has occurred with regard to securities represented by that global security and has not been cured or waived.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of securities covered by the prospectus supplement. If a global security is terminated, only the depositary, and not we, the trustee, the agent or other third party, as applicable, is responsible </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for deciding the names of the institutions in whose names the securities represented by the global security will be registered and, therefore, who will be the direct holders of those securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_550"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sheppard, Mullin, Richter &#38; Hampton LLP, Menlo Park, California will pass for us upon the validity of the securities being offered by this prospectus. If the securities are being distributed in an underwritten offering, certain legal matters will be passed upon for the underwriters by counsel identified in the related prospectus supplement.</font></div><div id="i8a6c5d41765441f4936b57d980c018da_561"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company incorporated by reference in this prospectus, and the effectiveness of the Company&#8217;s internal control over financial reporting have been audited by Deloitte &#38; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are incorporated by reference herein in reliance upon the report of such firm, given their authority as experts in accounting and auditing.</font></div><div id="i8a6c5d41765441f4936b57d980c018da_572"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including Kratos. You may also access our reports and proxy statements free of charge at our Internet website, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.kratosdefense.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The information contained in, or that can be accessed through, our website is not part of this prospectus. The prospectus included in this filing is part of a registration statement filed by us with the SEC. The full registration statement can be obtained from the SEC, as indicated above, or from us by writing to the address listed under &#8220;Incorporation of Certain Information by Reference&#8221; below.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus is part of a registration statement that we have filed with the SEC relating to the securities to be offered. This prospectus does not contain all of the information we have included in the registration statement and the accompanying exhibits and schedules in accordance with the rules and regulations of the SEC, and we refer you to the omitted information. The statements this prospectus makes pertaining to the content of any contract, agreement or other document that is an exhibit to the registration statement necessarily are summaries of their material provisions and do not describe all exceptions and qualifications contained in those contracts, agreements or documents. You should read those contracts, agreements or documents for information that may be important to you. The registration statement, exhibits and schedules are available at the SEC&#8217;s Internet website.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should rely only on information in this prospectus or incorporated by reference herein. We have not authorized any person to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus is accurate as of any date other than the date of the front page of this prospectus, regardless of the time of delivery of this prospectus or any sale of the securities offered by this prospectus. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_583"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC allows us to incorporate by reference the information we file with it, which means that we can disclose important information to you by referring you to another document that we have filed separately with the SEC. The information incorporated by reference is considered to be a part of this prospectus. We hereby incorporate by reference the following information or documents into this prospectus&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000106925824000007/ktos-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10&#8209;K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December 31, 2023, filed with the SEC on February 13, 2024&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the description of our common stock contained in our Registration Statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1069258/000107299399000158/0001072993-99-000158.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 8&#8209;A</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (File No. 000-27231), filed under Section 12(g) of the Exchange Act on September 3, 1999, including any subsequent amendment or report filed for the purpose of amending such description, including Exhibit 4.4 to the Annual Report on Form 10-K for the fiscal year ended December 29, 2019 (filed with the SEC on February 24, 2020).</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this prospectus or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incorporate by reference any future filings (other than information in current reports furnished under Item 2.02 or Item 7.01 of Form 8&#8209;K and exhibits filed on such form that are related to such items) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, until the termination of the offering of the securities covered by this prospectus. Information in such future filings updates and supplements the information provided in this prospectus. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon written or oral request, we will provide to you, without charge, a copy of any or all of the documents that are incorporated by reference into this prospectus but not delivered with the prospectus, including exhibits which are specifically incorporated by reference into such documents. Requests should be directed to&#58; Kratos Defense &#38; Security Solutions, Inc., Attention&#58; Investor Relations, 10680 Treena St., Suite 600, San Diego, California 92131, telephone (858) 812&#8209;7300.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><div id="i8a6c5d41765441f4936b57d980c018da_58"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:48pt"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:120%">12,987,013 Shares</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Kratos Defense &#38; Security Solutions, Inc.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Common Stock</font></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:16pt;text-align:center"><img alt="kratoslogo.jpg" src="kratoslogo.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:333px"></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Prospectus supplement</font></div><div style="margin-bottom:46pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Baird</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">RBC Capital Markets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Truist Securities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Raymond James</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:25.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">B. Riley Securities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">The Benchmark Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Citizens Capital Markets</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"><tr><td style="width:1.0%"></td><td style="width:5.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Noble Capital Markets</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Academy Securities</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-207">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-208">424B5</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-209">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="ffd:RegnFileNb" contextRef="rc" id="ixv-210">333-277222</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-211">0001069258</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-212">KRATOS DEFENSE &amp; SECURITY SOLUTIONS, INC.</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="rc" format="ixt:booleanfalse" id="ixv-213">The prospectus is not a final prospectus for the related offering.</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001069258</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-06-26</xbrli:startDate>
              <xbrli:endDate>2025-06-26</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001069258</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-06-26</xbrli:startDate>
              <xbrli:endDate>2025-06-26</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-238">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-239">KRATOS DEFENSE &amp; SECURITY SOLUTIONS, INC.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word">
            <p style="margin: 0pt; text-align: center;">
              <b>Table 1: Newly Registered and Carry Forward Securities</b>
            </p>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-240">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-241">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-242">Common Stock, $0.001 par value per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-243">457(r)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-244">14,935,065</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-245">38.50</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-246">575,000,002.50</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-247">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-248">88,032.50</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-249">575,000,002.50</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-250">88,032.50</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-251">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-252">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-253">88,032.50</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-254">1a. Includes 1,948,052 shares of common stock of the Registrant issuable upon exercise of the underwriters' option to purchase additional shares of common stock.

1b. The filing fee is calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended (the "Act"). In accordance with Rule 456(b) and Rule 457(r) of the Act, the Registrant initially deferred payment of all of the registration fees for Registration Statement No. 333-277222 filed on February 21, 2024.

1c. This registration fee table shall be deemed to update the "Calculation of Filing Fee Table" in the Company's Registration Statement on Form S-3 (File No. 333-277222) in accordance with Rule 456(b) and Rule 457(r) under the Act.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>kratoslogo.jpg
<TEXT>
begin 644 kratoslogo.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_X1C:17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   "]    !0
M +T    %    1TE-4" R+C$P+C(T   R,#(T.C R.C(P(# X.C0W.C(V  $
M : #  $    !          @   $$  $      0   0$$  $   !%     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   # %P        @ "  ( /_8_^  $$I&248
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M.;:^U/2I[:U2.0-+)C X[\UF?$KXFWWB'4Y].TNY>#2(6*#RC@SD=6)]/04
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MEZ5KE_"[Z5:7LT2MAS;JQ /OCO0,^GOB)J^F:;X)U,7\\0\^!HHHF89D8C@
M=Z^355G8*JEF8X  R2:M:A9:C93A=2MKF"5AQ]H1E)'X]:[KX<>*O"^AZM;+
MJ.@ SNRH+]I3(8R>,[", ?3F@#V?P_HMUIOPF@TN92+I;!]RDY*LP+8_#.*^
M8II99I2TSL[@!<N<G & /P  _"OK_6Q>R:'<MI<H2\$>^ D;@S#D CN#T_&O
MD;4YA<ZG=3"V6V\R5F,*DXC)/(&>V:F1[>3_ &C5\8C[9::%K*DL+JQ6"4^D
ML)V,/^^=A_&O0-(\&K+\ KV5HO\ 2;@G4%..?D^[_P".@_F:XSPO91>)M-E\
M,/*L5RUPMU:LQQD\+(OUV<C_ ':V[;Q[JJ^-TLH=16VT59_L:6\D>^%(1\@R
MO!Z#DY[T7T.6K@9NM.,=EJ<KX+_T.35=:;@6%C((S_TUE'E)_P"A$_A6+#-+
M;RB6&1HY!G#*<$=J[#Q7IT7@^QG\-Q2;[FXNFN)V!SMB4D0I]2/F/U%<E:2)
M%>0R20"=$<,8B<!^>A^M)GI992Y*#DUO^1]6^!;:6T\#:-#-G>MJF0>V1FJ'
MQ3_Y)KK7_7)?_0UK:\-#43X?M)-5*_;9$\R1%7:L>>0H'8 8'X5B_%/_ ))K
MK7_7)?\ T-:M'SU1WFWYGRA7UW\/O^2?:!_UY1_RKY$KZ[^'W_)/M _Z\H_Y
M4$LJ_$[4VTKX>:M,C%7DB\A2#S\YV_UKY.KZ;^-BLWPXN2O1;B(M]-V/YD5\
MR4 CZI^%&A1:)X!T]PBB>]C%U*X'+;^5_)2*[:LCPK*D_A#198ON/8P%?IL%
M:] CYA^,>@1:)XYDFMD"07\8N H& K]& _$9_&H/A#JSZ9\1+",,1%>;K>0>
MN1E?_'@*Z;]H"1#K^DQC[ZVSD_0MQ_(UY_X%BDF\?>'UB&6&H0,?H'!/Z T#
M.D^->GW%I\1KFYEW&*\ABDB..  @0C\U)_&N<\$^)SX1\3V^K?9_/C0%)(\X
M)0]<'UKZ;\8>"],\::8MK?ATDC.Z&>,X:,_U!]#7B&N? _Q-ISL^FF#4X<\"
M-Q')CW5L#\B: /6-,^+7@W54"/J0M&88*72%,>V>GZU3A^$_@+5%-W;(URDI
M+B2&\+*V>>"#BOGO5/#6MZ+G^TM+NK91U9XSM_[ZZ57TW5]1T>X$^G7L]K*/
MXHG*Y^OK0%CZV\,^$M)\(VT]OI$4D<4[AW#R%^0,=ZW*\]^%7CV;QCI4UO?@
M?VC9A1(XX$JGHV.QXYKT*@1YW\;/^2;W'_7Q%_Z%7S)7U+\7--O=5\!36EA:
MRW-PT\1$<2[B0#S7SY_P@?BO_H7[_P#[\F@:/H9O#5OXL^$VF:7-A7?3+=H9
M",^7((UVG_/:OF'4=/N-*U&XL+N,I<6[F-U]"*^P/"\,MMX2T:">-HY8K&!'
M1A@JPC4$'\:\R^,GP_N-6>'7M&LWFO,B*YBB&2Z_POCN1T^F/2@$87P5\<FP
MOO\ A&=0E M;ALVC,?N2'^#Z-V]_K7O<_P#Q[R_[A_E7R.G@;Q;&ZNF@ZBK*
M<AA$00:^D_!FK:IJ_A11K-A<6FI0H8I5FC*^8<<./K_.@&?*-_\ \A"Y_P"N
MK?S->]_L_P#_ "*^J?\ 7[_[(M>27G@;Q3)>W#KH%^5:1B#Y)Y&:]H^">CZE
MHOAW48=2LI[21[O>JRIM)&P#- $OQPTV*[\ M>-&#-9W$;J^.0&.PCZ?,/R%
M?-5?77Q TR76/ FKV4$333/!F.-1DLRD$ >^17S/_P ('XK_ .A?O_\ OR:
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MSH!%/X1_$/2U\/0:#JU]':W5J2D#SN%61"<@ GC(SC'TKTS4O$NB:/:&YO\
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MQ_*O?JYOP5X.LO!>ABPMCYDSG?/.1@R-_0#H!724"*U_>QZ?:FXE1W4,J[4
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MM+<,GRQ(7.T#. ,\5FSR7EE/:EKU+E))A&8VB4'G/((]*MZQ_P @6^_ZX/\
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MMB[L[6=NS,<DF,9)HHH FA@AMTV0Q)&O7"* *58HTD>18U#OC<P'+8Z9-%%
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M;7,
M      UD97-C   !(    $!C<')T   !8    #9W='!T   !F    !1C:&%D
M   !K    "QR6%E:   !V    !1B6%E:   ![    !1G6%E:   "     !1R
M5%)#   "%    "!G5%)#   "%    "!B5%)#   "%    "!C:')M   "-
M "1D;6YD   "6    "1D;61D   "?    "1M;'5C          $    ,96Y5
M4P   "0    < $< 20!- %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!"
M;6QU8P         !    #&5N55,    :    ' !0 '4 8@!L &D 8P @ $0
M;P!M &$ :0!N  !865H@        ]M8  0    #3+7-F,S(       $,0@
M!=[___,E   'DP  _9#___NA___]H@   ]P  ,!N6%E:(        &^@   X
M]0   Y!865H@        ))\   ^$  "VQ%A96B        !BEP  MX<  !C9
M<&%R80       P    )F9@  \J<   U9   3T   "EMC:')M       #
M */7  !4?   3,T  )F:   F9P  #UQM;'5C          $    ,96Y54P
M  @    < $< 20!- %!M;'5C          $    ,96Y54P    @    < ',
M4@!' $+_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0'_P@ 1" !: 4T# 1$  A$! Q$!_\0 '@   00# 0$!
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M%Y)'7?N=:OPFG,G&4VY.K+U]5F'+A'N0XHO)
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M*1C >7]N5'8SGGG;GK]!7LQL/TF0ER?B'Q,LW*CZ\SJ#6%ER5DA9T4^)EFX
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MT:J-C"SG5&2M%5&I=L[(X[_$AQ]%I&TW?UJ3PXD70C?)91N*1 .7$0E)%,O
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MW\SYG_/X?8QNCIJZ-7TOROW<<MQMI/L'G^G?^E1XB#*"&%>S??W_  Z5\?\
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MX20+V2&?_A,L^%)MTQM)R\+^$>4TMGVT.,Q&QNR\+%?Z75!FY0Z_NG/RH9F
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MYCR-%_O[K4[^;R=NJ[I\LYER^K7L66*9TVK6T-P3M8 &.A#$^R.0>4LD^ID
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MQ$0+)(8B--.*?,P93"X;F+'P51/OC)T<2O/TAAECW:JQ??725^L4LL4X(]"
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M%=J"F8\Y#-$?82]>@LHY@(& ,XS8N%JW^<$KVD(P^Q+['-W M@M<L_7.V=Y
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M%K<2![P9QPYVF@[L^_2+%^_M1QZD8+"YZ"Q6\50
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M3PS9*20.Z;0DT3. (")4SC2QTS^9H"+ 26]C>_#6K*H[0I=@T CK1H*'P+H
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MA -(QAC?!$QH"\I(P%3SQY2UX  9\A:4@I>Z4F, +PE804>L 1(8D 2&X"2
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M"V?)TVSEKWBPKHD( -DL^P\)D04+_P"=_\0 )1$! 0$  @$$ @,  P
M 1$A #%!$%!188'P('&1,$"A_]H " $" 0$_$/\ G@"M_<OA4.X@HJJ ^J4X
M=@1>P&O+E  "YTE"^,3$9E0C]C[(\J@L((XBB0HHE-)?XC?O/GCMD\%5?Z7
M?'RE*U]CK$=0H@66L"M$@-8BU9?S4$_*#\_P0Y*B^08?XOY3ZYFL/QE  !JL
MOH H='X*'0II^&GL81Q.PL@ DCT*JQJR111HQ-'N)T_[P".@#^DOKWP4R;T
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M4'20$!B800#Y:  ,A$0"4 :G96ML5Q'G@H>7.B*O!=M7CH!71&4 )M*D16R
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9,;+U!NXP(/6THV$=6;QTP/TL7T+_ )W_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>kratoslogoa.jpg
<TEXT>
begin 644 kratoslogoa.jpg
M_]C_X  02D9)1@ ! 0$!] 'T  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &A!8T# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 C':":\$_:>^-5K\,?#[F1QNFB*C![G(KV7Q/K$>BZ->7,AP(XF?KZ"OR
M._;$_: B^(6I7&EVDWS6LNP\YZ'-9S=EH?29'ELLPQ*5O=6YX%\3?&MYXN\4
MZC<2W#2022953VKL?V:]*&J^+0A7=AUKQ]W,C%F.2:^A?V-85F\=$,,C>M8'
M[1F$50P$U!;(_7WX1VOV/P+I\6,;1_05V5<[X"01^&;4#@8KHJZEL?SO4=YM
MA1113,PHHHH **** "BBB@ HHHH **** "OS!_;L\.6S>)+^\,(\WYOFK]/J
M_/K]N;0':WU"[QQ\U95-CZ3(*CIXV-GN?FK97T^GW"SV\ACE7HPK]&/V&/CL
M\.CVND:A<^=<2;0"YK\X*[_X/^.KKP?XPL+A9BD$;9(K*]C]DSG +'X64.JU
M/WSMY5FA1U((90>*DKQ;]FWXJ0?$?PR+A)-^U%'7/M7M%=*=U<_GVM2E1FZ<
MMT+1113,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*;YBCJP_.F27442%C(N
M!_M"@"6BN>NO&EC:[MTB<?[0KG[_ .,FD:><.R_]]T >@T5YC_POC1/[R_\
M?=+_ ,+WT3^\O_?= ['IM%<)IOQ:TK4G"QNF?]\5NV?C"RO)?+1US_O"@1O4
M5%'<Q2+D.I_$4_<IZ$?G0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,]1_P!_U_PK\8Z* Y3]G/\ AY1\,?\ GJ/^_P"O^%'_  \H^&/_ #U'_?\
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M/*/AC_SU'_?]?\*/^'E'PQ_YZC_O^O\ A7XQT4!RG[.?\/*/AC_SU'_?]?\
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MCB1<BG5XS\$_'=S=Z-!9:O+NU$XSS7LU @HHHH **** "BBB@ HHHH ****
M"OG_ /;"_P"1"_X"U?0%?/\ ^V%_R(7_  %J!H_%;XF_\CA>?Y[FN5KJOB;_
M ,CA>?Y[FN5H- HHHH **** "OT2_P""8_\ QXWG^\__ *%7YVU^B7_!,?\
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M7_P4X_Y!-G]5_P#0Z_.6OT:_X*<?\@FS^J_^AU^<M!:V"BBB@84444 %%%%
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MTA\9&<]A7X8U^EW[!?Q1CGN-.T/SP6&WY,_A03(_26BBB@@***@EOH89 CN
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M?_PJ?Q5_T"9J/^%3^*O^@3-0!R%%=)??#KQ!IL+2W&G21HO4FN<92K$'J.*
M$HHHH **** "BBB@ HK=TWP1K6KJK6EC),K="M:7_"I_%7_0)FH Y"BNO_X5
M/XJ_Z!,U'_"I_%7_ $"9J .0HKK_ /A4_BK_ *!,U'_"I_%7_0)FH Y"BNO_
M .%3^*O^@3-1_P *G\5?] F:@#-\"_\ (Y:+_P!?<?\ Z$*_H%^#_P#R3'PY
M_P!>B_S-?A-X)^%?B>'Q=H[OI4H5;J,D_C7[N?">%[7X;>'XY5V.EJH8'MR:
M")'37MY'9V\DDC;0JD_D*_/K]M/]JA=/TNXTS2[SS+F+*E V*^A_VK_C5'\-
M?"YDMYU\R2-E(SZY%?B]\3_$TOBKQEJ&H/(S"9LX+9% )&-XBUZ?Q)JDM]<$
MF23KSFLRBB@L**** "BBB@ HHK7T/PGJOB(XT^T>Y.<?+0!D45[S\-OV6_$_
MB60?;M'FB0G@D=J^A_#O_!/VVOXXC<P,A8<Y!H%<_/\ HK].H/\ @FKX?>%6
M9L,1Z&L?7/\ @G/I-E"3 N\^P- 71^;M%?77Q"_8KU/0K=VT[3I)F&<;17SW
MXF^$/B;PW*YNM*EAC7^)J!G$T5)/;R6TA21=K>E1T %%%% !1110 Z.0QR*P
MZ@YKZC_9)_:"O/ASK$</G&-)I A^;L>*^6JL6-X]A=PSQDAHV##!]* /Z'_A
MWXULO%WAVPN()Q+-)$&8>]=97YJ?L!_M&3ZMJ#Z=J<WDQ0@QIO/7Y:_2+3[Q
M+ZSBG1MRN,@T&;+-%%% @KS7XY?$2+P#X+N;]9MDD>>_M7I5?GK^WA\7H(]+
MU'0!= 2?-\F>?2@#X?\ VCOBW<?$3QE+>&4R(V[G=GJ:\6I68MR22?>DH-0H
MHHH **** "BE52S #DGBO4_A!\%=2^(>I"$6;O'N R/2@#S?3=)N=6E\NVC\
MQ_2NLM?@QXLO8UDATQF5NA_R*_2'X+?\$_=#M(;>]N\1S. 65@:^G-%_9ST/
M1K6.!%B8)_L4$\Q^)TGP!\;Q0^:VD.$]<G_"L>_^%OB/34+W%@R**_>BZ^#^
MDW5B+8Q0A1WV"N$\2?LE^'O$5NT4GEJ&_P!B@.8_"RZM);.3RY5VMZ5#7Z&_
MM*?L+VGAK3[O4='A-Q*F=H0&O@/6_#]_X=NOLVH6[6TW]UNM!5S.HHHH ***
M* "BBB@#Z/\ V,?BDGPU\9/<2S^4)) .3ZC%?K3)X/TKXW> ;)[U@\<JD[L9
MK\$=+F:'4;5E8KB53P<=Q7[=?LA^-/[4^'^CV!DW%$QU]A01(>O[.UAX;?\
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M "3G6_\ KG7X;ZM_R%+S_KL__H1H+B5:***"@HHHH *5/OK]:2G1_P"L7ZT
M?IM^Q_\ "/3_ !-H>G23K$2V,[ESZ5];_P##-VB_\\[?_OC_ .M7@_[#/_(N
MZ7^'\A7VY09GC?\ PS=HO_/.W_[X_P#K4?\ #-VB_P#/.W_[X_\ K5[)10(\
M;_X9NT7_ )YV_P#WQ_\ 6H_X9NT7_GG;_P#?'_UJ]DHH \;_ .&;M%_YYV__
M 'Q_]:C_ (9NT7_GG;_]\?\ UJ]DHH \@M?V==&M;B.58X,HP8?)_P#6KT>[
MFM_#OA^1&D6-8(&V_@":UZ^<_P!K[XIK\/\ PUE90IFB*]?7(H&?GU^VM\;9
MO&>I7ND+*=EO)M&T^^:^/RQ8Y)R:Z/XA:T^N^+M2NVD9Q+)NY-<W0:(****
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MJK1QO-<1;V5ES@].XK\X?V-?"]MXA\1YGV?NY01N'IBOV?\  ]HEEX5TV%
MJQ8&/K03(VH8$A4*B*H']T8J2BB@@**** ,S7-#M]<L7MYHXV5O[R@U^7O[<
MG[.L%EX@O-9MXPJ1[O\ 5C _SQ7ZJU\Z_MD>$8;OX2ZUJ!5=ZCKCGH:!H_#=
MEVLP]#BDJ2XXN)1_M'^=1T&@4444 %%%% $MJVVYB/HX/ZU^IW[ OB^#4;JS
ML4N%=U"C9FORLK[8_P""8-U-)\7'1I79 R_*6.*!,_7NBBB@S"BBB@ HHHH
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MRAMY)(YGVEU4D"OV _9%_9SM_AOH(>ZA2626,."XR1G!KR#]B+]F)+724O\
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M9V4*1H$ 11Q]*_,[_@G_ .'TNM)L;LIDKMYK].8>(D'^R*"&/HHHH)"BBB@
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MUS:KF.($MQ0!5\0:]<ZY?333R>8&<L*RJDN(6MYGB;[RG!J.@ HHHH ****
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MSK?_ %SK\-]6_P"0I>?]=G_]"-!<2K11104%%%% !3H_]8OUIM.C_P!8OUH
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MJKT044459XH4444 %%%% !1110!\_?M9?\DYUO\ ZYU^&^K?\A2\_P"NS_\
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MO/@9^W%)X,,,&JSR763M^?/]*^**5',;!E.".E '[=?#O]M'0?&<$*JD438
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MH^'4UH8_,SNXQ[5^)7QG\.CPSXQFLPFS;GC\:_H'UG2XM6M#!*@=3V-?C_\
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M&L?#O5;EKB+RX(^VTB@T3/'Z***!A1110 4444 %%%% !1110 4444 %%%%
M!1110 445V?P^^&.J>/KV&.P7=N;;]TF@#(\*^&;CQ)JEM;0#+2N$'&:_3C]
MCS]DB3P[%'J&N6GFK(/,C)7'TI?V3?V,V\.1)>>)+'?)_K(SLQ].M?=^CZ1!
MH]G#! FQ(UV@4$-DFEZ?%IMC#;Q+M2-=H%6Z**"0HHHH *^>_P!J;X0Q>-O!
M%X+>WW73YPV,]J^A*KWUC#J,!AF7<A[4 ?ST?%;P-<^ ?$C:=<KMD&>V.AKB
MZ_6#]K_]E,>)([[6-.L_W@W8;;GK7Y?>,/!M]X+U(V=^,2Y/;'2@T3,"BBB@
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%;_A'PE=^*]0B@M1DF15
M/&>] "^#?"=SXJU2*"W&3YB@\9[U^O\ ^Q_^SY;>"=%T[6&M-D\B@E\8KS+]
MD?\ 9'32OLVI:U9;HI '!VX[5]Z:/I<&C:?%:6Z[(HQA5H(;+:J$7 X%.HHH
M)"BBB@ HHHH **** "BBB@ HHHH **** "OG_P#;"_Y$+_@+5] 5X1^UM8RW
M_@;9$NYMK4#/Q-^)O_(X7G^>YKE:]7^(GPPUVZ\57<D=ME3TZ^IKFO\ A4_B
M#_GU_G06<;179?\ "I_$'_/K_.C_ (5/X@_Y]?YT#.-HKLO^%3^(/^?7^='_
M  J?Q!_SZ_SH XVOT2_X)C_\>-Y_O/\ ^A5\/_\ "I_$'_/K_.OOG_@G'X2U
M#P_9W8O(MA+-_P"A4$O8_2*S_P"/6+_=%35#:\6T?^[4U! 4444 %%%% $4\
M"W$>QQD5\#?MN?LY6>J66H>(8;7-PN[#[?7FOOZN7^('A&V\8>'Y["X7=')U
M&,T#/YW]2TN;2Y_*G&'JI7UG^UQ^SCJ?A_Q_(FCV?^A@OSC'<5\_?\*G\0?\
M^O\ .@TN<;179?\ "I_$'_/K_.C_ (5/X@_Y]?YT <;179?\*G\0?\^O\Z/^
M%3^(/^?7^= '&T=.:[+_ (5/X@_Y]?YT?\*G\0?\^O\ .@#L_P!GGXO7/PW\
M3K="?REW+SG%?LW\"?B=:>./!MA,)?,GDZG.>PK\,E^%/B!6!^R]#[U]Q?L7
M>.O$7AWQ!::=JG[JPCV_Q&@EGZ?450T74DU2Q6>-MRMWJ_00>(?MD?\ )"-;
M_P _PM7X.R_ZQ_J:_>S]K?3YM4^"6LV\"[I&Q@?\!:OQ%D^%'B#S&_T7N?6@
MN)Q=%=E_PJ?Q!_SZ_P Z/^%3^(/^?7^=!1QM%=E_PJ?Q!_SZ_P Z/^%3^(/^
M?7^= '&U+:_\?4/^^O\ .NM_X5/X@_Y]?YU);?"GQ MQ$3:_QCU]: /T>_8!
M_P"/RV^@_E7W_7PC^PKX?N])OK<7";< ?RK[NH,V%%%% @HHHH *Y'XL6:ZA
M\/=9MV&0\.#^===65XHM/MV@WD&,[TQ0!^#7[0'@^'POXDN!%'L\RX<GCU)-
M>35]I_MN_"74!XDA:QM]RM)D\>QKY>_X5/X@_P"?7^=!H<;179?\*G\0?\^O
M\Z/^%3^(/^?7^= SC:*[+_A4_B#_ )]?YT?\*G\0?\^O\Z .-JYI>JSZ/=">
MW;:XKIO^%3^(/^?7^='_  J?Q!_SZ_SH _7W]A/Q>=5^$=DMP^Z8[>_M7U)7
MP)^P[-J&BZ/8:=<C9C;D9K[[H,V5M0O$L;5YG.%7K7Y4_P#!1;XM7R^-%LM/
MF_T:0E6&?:OTC^,^K2:7X!U*6W/[]5^7]:_&?XZ:3XF^('B-[F6'S-LC8.2:
M!H\"D<R2,YZL<FFUV7_"I_$'_/K_ #H_X5/X@_Y]?YT%G&T5V7_"I_$'_/K_
M #H_X5/X@_Y]?YT <;179?\ "I_$'_/K_.A?A/X@+ ?9?YT =A^S'X,3QMXY
M6RDC\P97C'J:_;;X+^'U\-> [.Q5=@3M^ K\Y/V!_@G?:9\1H+S4+;9$2GS8
M]Z_4^SLTL8!%']T4$,GHHHH)/+_C[XTA\+_#_4IM^R9!QS[&OQ<^,WCJ3QUX
MB>ZDD\PJ[<YK]2?VNM#\0:YHFHVVG1>9"^>Y]Z_*?Q)\*]?\/R3/>VWE@,2>
MOK7//<_5N$:="G"56<ES'%T4K*58@]0<4E0?IX4Y&,;!AU!S3:<JEV"CJ3B@
M#[#_ &$_BI<:!XEFCN)MJ%]HY]5 K]7O#FH#5-'MKH'(D7.:_"WX5Z'XHT_6
M+6;2H<AID)Y(XR*_9WX'SZ@_@325OAB41?-S6M-]#\9XKPM.-=5Z;6IZ1111
M6Q\ ?FW^WI\(H8;/4?$'D8<[OFQ^-?FA7[K_ +7G@,>+OAA=6T4?F2MNXQ[5
M^.WC#X)ZYI.K-!%:X49[&@M'F-%=E_PJ?Q!_SZ_SH_X5/X@_Y]?YT%'&T5V7
M_"I_$'_/K_.C_A4_B#_GU_G0!QM%=E_PJ?Q!_P ^O\Z/^%3^(/\ GU_G0 SX
M;>.-1\'^(+%[&3R]]Q&&Y[%@#7[H_L_^,H_$GP_T7+[Y_(&[FOPWL?A;X@@O
M+>3[-]R16[]CFOT[_8;\3:DTD5A?G:D*[0,^U!,C[@HIJL'4$=*=00%%%% !
M1110!\_?M9?\DYUO_KG7X;ZM_P A2\_Z[/\ ^A&OW1_:DT^;4/ &L10KN=H^
M!7XOZI\*?$#:E=D6W!F<]_[QH*B<)179?\*G\0?\^O\ .C_A4_B#_GU_G06<
M;179?\*G\0?\^O\ .C_A4_B#_GU_G0!QM.C_ -8OUKL/^%3^(/\ GU_G2I\)
M_$&]?]%[^] 'ZB?L,_\ (NZ7^'\A7VY7QG^Q7H=UI.A:;'<)M9<9_(5]F4&;
M"BBB@04444 %%%% !1110 4444 -=!(,&O&?C%^SSH'Q TV;SK7S)WSG@&O:
M** /QV^.G[%>O:#?7%SI=ALLES@[#7R7XD\,WGA74#9WJ[)AVQ7]$^O^&[7Q
M%9-;70S&W7C-?,GQ8_8?\'^)VFODM=]WSC]T*"DS\7:*^R/B[^Q#XBTR]E;1
M=,S;KGG:1_2O -<_9_\ %^@;C=V.P+UZ_P"%!=SS:BKNIZ1<:3)Y=PFULXJE
M0 4444 %%%% !1110 458LK&6_F$4*[G-=MH?P1\4^(-OV.SW[NG7_"@#@:M
MZ5I<VL7T=I;C,LAP!7T]\,/V+/%VKWT#:CI?^C'[QP3_ $K[9^%'[!_A336@
MO;ZSV74>"/W8H%<^&O@_^R%XF\4W=M-/9;[8D%OD/2OT=^ O[*.@>";..6>R
M\NX50P^4#FO<O"G@#3?"-JL-DNU0 .F*Z8<<4$7(K6U2SA2*,850%%3444""
MBBB@ HHHH **** *6K:3!K5D]K<KNB;J*^-OVFOV.].\56=Y>:38[[SG8=M?
M:U-DC$BE3TH _ #Q]^SOXJ^'\TPU*V\L*3_"1Q7ESJ49E/4'!K^@'XF? 7P]
M\1()FU"+>[#^X#7QI\7/V"=.M[6[DT+3]\N"5_=XYH+YC\R**]J\0?LF>/\
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M=W^RGX4O)VE=!N;_ *9BH?\ ADGPC_<'_?L?XU[E10!X;_PR3X1_N#_OV/\
M&C_ADGPC_<'_ '['^->Y44 >&_\ #)/A'^X/^_8_QH_X9)\(_P!P?]^Q_C7N
M5% 'AO\ PR3X1_N#_OV/\:[/P+\&M%\ JRV"X#?[.*[^B@!JKL4*.@IU%% !
M1110 4444 %%%% '!^,_@_H_C:X::^&6;K\H-<5_PR5X1_N#_OV/\:]QHH \
M-_X9)\(_W!_W['^-'_#)/A'^X/\ OV/\:]RHH \-_P"&2?"/]P?]^Q_C1_PR
M3X1_N#_OV/\ &O<J* /#?^&2?"/]P?\ ?L?XT?\ #)/A'^X/^_8_QKW*B@#P
MW_ADGPC_ '!_W['^-7M)_9?\+Z/<^="HW?\ 7,5[)10!0T71X=$L5M8/]6O3
MBK]%% &5XF\.V_BC2)=/NAF&3KQFO(S^R5X1)SL'_?L?XU[C10!X;_PR3X1_
MN#_OV/\ &C_ADGPC_<'_ '['^->Y44 >&_\ #)/A'^X/^_8_QH_X9)\(_P!P
M?]^Q_C7N5% 'AO\ PR3X1_N#_OV/\:5?V2_"*L#L''_3,5[C10!Q/@OX4Z3X
M(F$EB &'^SBNVHHH **** "BBB@ IDD8EC*'H:?10!YMXW^!>A>.[A9K]067
MI\@-<M_PR3X1_N#_ +]C_&O<J* /#?\ ADGPC_<'_?L?XT?\,D^$?[@_[]C_
M !KW*B@#PW_ADGPC_<'_ '['^-'_  R3X1_N#_OV/\:]RHH \-_X9)\(_P!P
M?]^Q_C1_PR3X1_N#_OV/\:]RHH \Y\(_ _0_!]S'-9J R=/D KT:BB@#&\2>
M%[7Q-82VER,QR=>,UY0_[)?A)V9B@R3G_5C_ !KW"B@#PW_ADGPC_<'_ '['
M^-'_  R3X1_N#_OV/\:]RHH \-_X9)\(_P!P?]^Q_C1_PR3X1_N#_OV/\:]R
MHH \-_X9)\(_W!_W['^-*/V2O"((.P?]^Q7N-% '$^#OA5I7@N1'LA@KT^7%
M=M110 4444 9NK:'!K$+Q3?=;KQ7DGC3]ECPMXPAE%V@)?\ Z9@U[;12:3W-
MZ=:I1=Z;L? OCW_@GYX;LXIWTRU#OR1^Z KY4^(G['OC#3;W;I&CF2/=CN./
MRK]HRJMU4'\*8UM"W6)#]5%1R(^GPG$V-PSO)\WJ?CS\(_V,_$>L2,-?TDQ#
M/&03_2OI?PC_ ,$^_#$YB>]M@K#!_P!4*^\%MXEZ1(/HHI^T#H /PHY$1BN)
M,=B).49<ODCPSP?^R9X3\*1PM;( RX/^K KV;2M)BTFTCMX?N1C XJ]15I);
M'S=6O4K.]25PHHHIF!0UK1X=;LS;S_</M7E>L?LP^%]:NS<3J-Y_Z9BO8Z*
M/#?^&2?"/]P?]^Q_C1_PR3X1_N#_ +]C_&O<J* /#?\ ADGPC_<'_?L?XT?\
M,D^$?[@_[]C_ !KW*B@#PW_ADGPC_<'_ '['^-'_  R3X1_N#_OV/\:]RHH
M\-_X9)\(_P!P?]^Q_C74>!O@3H/@*\:XL% =CD_(!7I5% #8XQ&H4=!3J**
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M%HH&WI^[ KUW ':EH I:7I<6DV_DQ?=^E7:**!!1110 4444 %%%% !1110
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MKI2T4""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8N4:,XQ74[#_ (:7O?\ H&R?]^Z/^&E[W_H&R?\ ?NNX'P>MR/\ 5Q_I2_\
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MW/\ "I/Y5XSXG^/W]A7SVZP[RK;>%KT;QIJZZ7I\I+ ;HS_*OD*\237O%5P
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M/7)&9E4Y]:\V:G=<IWTW%-\R/(/^&EKW_H&R?]^Z3_AI>]_Z!LG_ '[KN?\
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M=Z](_P"%.V__ #SC_2N^I3]F[,XJ=3VBNCAO^&E[W_H&R?\ ?NC_ (:7O?\
MH&R?]^Z[G_A3MO\ \\X_TH_X4[;_ //./]*RT-3C;/\ :/O;F8(=.D&?^F=>
MI>'O&<NL:"]\T#*P ^7%8=O\(K>&0-L3]*[31=!CTNR^S[5V^E5+E]DTOB,_
M>]HGT/*?$GQ\N-!U 0-9MC.,E*['P#\2XO&%N9&*QMZ'BN3^+WP[74HYKR%
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MGQ,^'<.CZ//*J*"OI7D'@+25U37+>%@"&]:>'MB')1Z!53I14F>Q?\-+WO\
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MZ\10!>?G_H:]@^!%LT.FRY[K_6NK _\ (OE<Y\=_OD3F?VC/^6'X5B_L\_\
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M(_ALWH?Q8GRM<M_:GC0;N0?7ZU]5?#6Q2ST(*% Z5\J6'_(Z)_GO7UKX"_Y
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MR+MY_NU\?:7_ ,C9;_\ 7<_UK[!^(G_(NWG^[7Q]I?\ R-EO_P!=S_6IR_\
MWF1U5/\ =6?9_A+_ )!L'_7-?Y5O5@^$O^0;!_US7^5;U=%;XV>9A_X:,K7M
M'BU:TD21-YV$#\J^3/B;X-NO#%]+=(-B,^1Q7V.>1BO)_C=I5M-I2EDR=O\
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MQ:M;I)'W7-:5>-_ G79-2MV61]VU<"O8QTK?$4_93<4<U"HZD;O<6BBBN<Z
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MW%?07QH_Y%^Z_P ]C7S[\*_^1GL_\]Q3RGXZGS-<=_!B?9]C_J5^E6:K6/\
MJ5^E6:<MSEI? @HHHJ34**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *K7T9DA8 9.*LT5$X\\7%E1?*[GR5\0OASKNI>(KF:"TWQMT.3_A
M7N7PIT6[TG0;>*YCV.O4?A7H.Q?[H_*EP!T&*Z*=1TZ7LD177MY*3Z"T445D
M,*HZU$TVFS(@RQ'%7J*F4>96'%\KN?*OCSX>:WJ&O02PVNY ^2>?\*]D^%.B
M7>DZ>R7,>QMM>B;5_NC\J7 '08K6E+V5!T%LR*T?;5E6>Z/#?CMX2U/7O*^Q
M0>;C%>/Z7X%\6Z-,S0677W/^%?:14-U&:3RU_NC\JQHQ]BK1-ZD_:146MCY&
M&G^.0,?8S_WV?\*7[#XY_P"?,_\ ?9_PKZX\M?[H_*CRU_NC\JUYC$^1_L/C
MG_GS/_?9_P *46/CG_GS/_?9_P *^M_+7^Z/RH\M?[H_*GS >0^!8M?ALXS=
MP[7[\G_"O//B;X.\0ZYXB=X[7?"<\Y/^%?46T>@I-B_W1^53*TJJJM;#IWI0
M<4]SROX.>#IM$T5%NH_+E&.*]5H  Z#%+6M2HZCNS*G35.]@HHHK$U"L[6]/
M%]8S(1DE"!^5:-%1."G'E949.+NCY(\3?#'6X]=DGM+3<&E#9Y]1[5[UX$M]
M2AT>*"[CV;8R.OM7=[%_NC\J7 ':M5)JC[%ZHBJE4J*IM8^4OB5\/-<U+5[F
M2WM=ZL>#S_A6)IOAGQGIL:I%9<#_ &C_ (5]C[5_NC\J/+7^Z/RJ*?[N/*C6
MK+VTE)H^1_L/CG_GS/\ WV?\*/L/CG_GS/\ WV?\*^N/+7^Z/RH\M?[H_*KY
MC,^1_L/CG_GS/_?9_P *?'X2\5:LP6[M,*W7DG^E?6OEK_='Y4;%_NC\J+KJ
MA:]&?/W@[X)P^='/=P;9%.?NU[AHNAP:+;B.$<8QTK2P/2EJY5')<O0S5-7Y
MGJPHHHK(U"N ^*^C76K::J6T>]MN,?C7?TA /49K*I35169I3FZ<E)'RKX+^
M'NMV/B.6::UVQE@<\_X5]-:#"]OID2.,,*O[5_NC\J=76ZK=-4^QS>S7M'5[
MA1116)J%%%% !1110!'.I:%P.N*^??C=X+U;7;J)K.W\P BOH:D*@]0#^%9.
MFG.,^QK&HXQ<>YX9\"_"6IZ#-*;V#RLY_E7N:_=% 4+T&*6NRK5=5\S.6%-0
M;:ZA1116!J%)2T4 </XU^'-CXBAD>1=TC?[->*ZK\'[K2[G?8VV=O3C%?45)
MM'H/RK.,>1WB[&CGS*TM3Y+FT7QG:-M@L_E_WC_A47V'QS_SYG_OL_X5]<>6
MO]T?E1Y:_P!T?E6W,9^A\E1Z7XVF.V2S^4]?F/\ A5ZU^%NIZQ,AOK;'//>O
MJ?RU_NC\J7:/0?E34DG>Q-GW/,? OPFL-"4/LVOU/RUZ4(1%;>6O0+@5)2TY
MS=3<48*&JW/GWXT>#=5UN,"TM_,Y]_6K/P4\(:GH>H*]Y!Y:U[QM!Z@'\* H
M'0 5.&?U:G*G'6Y6(7UB2E+H"]*6BBI&%-<96G44FKJP'SU\:/!>JZYK+R6E
MOYB'/-:'P7\(ZGHEFJW<'EG->Z%0>H!_"@*!T %7AY?5XN*ZAB/]H44^@B<*
MOTIU%%2 4444 %%%% $5Q")HRIKYG^)_PSU*\U2XN+*VWLW2OIVF[5/4 _A6
M3IIS4^IK&HXQ<>Y\5:;\*_$<UR!/983ZG_"OJ#X8>'7T30(X94V.,<5VNQ?[
MH_*EKM]L_9^SL<DJ:E-2;%HHHKG-@KS_ .)OA5]<LYC&F^3;Q7H%)C/45C4I
MJHK,UIU'3ES(^)9OA?XFAN9A'9?(SG')]?I7I'P<^&^HV%R[ZA;^7SD5](^6
MO]T?E2A0.@ _"NVG6=/9'+5IJJK,BLX_)MHT_NC%3445B]7<T6BL,D&8V'M7
MS9\5_ NL:O=W#6UMO#=.O^%?2U-VJ>H!_"L94U*2GV-X5'!-+J>._"+PSJ&C
MPP"ZA\LC&:]DI H'08I:ZZM5U6FSCITU232ZA1116)L%<EX^TV?4-)N8X$W,
MRX KK:2LJE-5(\K-*<W3=T?'^@_#/7[?Q"DSVF(_/+9R>F3[5](7\%[%X>$,
M*9?R=N/?%=?L7^Z/RI<#TKHK2=:DJ3T2,5%*K[4^0;KX=>(=1\0-+-:?N_.#
M9R>F?I7TSX*T3^R=*ME9=KA,$5TFQ?[H_*G5:J<M-4DM!5(^TJ>TD]0HHHK$
ML**** .+^)/AUM9T&:.)-\C=J^?O#?P]\0:-XE@E2TQ$O?)]1[5]:4FQ?[H_
M*E1_<3<X]2ZDO:4_9R,OPZURUF/M*[7P*U6Z&BEJYOG;9C"/)%1/$/CAX4U+
M7;E#9P^8!_A6)\&?!.K:++(;NW\L%CZ^M?1)4'J,T!0.@ _"C#OZO>W4TK_[
M1!0?09;J5@0'J!4E%%22M%8****!A63X@T"#7K,P3C*GVK6HJ914E9E1DXNZ
M/GOQ5\%8H[EY;.'<W;Y:YEO"7B;2X]MK:9 ]R/Z5]4[1Z4FQ?[H_*G&\5:X2
M:D[M:GR2UCXYSQ9_^/'_  H33_'#, UGQ_OG_"OK;RU_NC\J/+7^Z/RJ^8D^
M4AX'\1:JP%U:8!Z\D_TKL_!?P4MXIDGNH=KJ=WW:]ZV+_='Y4N!Z5I&IR:Q1
MG*+DK-E33=-CT^W2.,<*,=*N445DVV[LM)15D%%%%(85R7Q&TV?4M#:*!-[\
M\5UM)C/49K.I!5(\K+IS=.2DNA\FZ3\.==A\5"=K3$?KSZ_2OI?PC:R6>EK'
M*NUN*VMJ_P!T?E3JZ54:I*ET1A*"E5=;JPHHHK(T"N1\=^$XM?T^<E=TFSY>
M*ZZBLJE-5%9EPFX.Z/C#6/A9X@M[J86MGE&8^H[_ $JWX/\ AGX@M-0BDFM-
MHW@GD^OTK["V+_='Y4;%_NC\JZZ-1T9*2U,JT5636QE:5;O#H,43##B(C'X&
MOG'XG?#_ %O4[R9[:UW@MD=?\*^I:;M7^Z/RKEG!3J*H;4YNG!P74^-]-\+>
M,]+4"*RX'^T?\*T/L/CG_GS/_?9_PKZX\M?[H_*CRU_NC\JW<V]S%14=CY'^
MP^.?^?,_]]G_  H^P^.?^?,_]]G_  KZX\M?[H_*CRU_NC\J7,4?*&GV/C=;
MI2]F0O\ O'_"O7=).NQ>$9E:'%S@87)_PKU+RU_NC\J7:/04YRYZ?LR%&U13
M/D35O _B;Q-K<<E[:?)N.3DG^E>Z?##P#%X=LL,FQL>E>C;%_NC\J6JA4]G3
M]G%!5C[6?/(%&T 4M%%9%A5:_LTO('1NZD59HJ914E9C3:=T?,_Q.^$]VUQ)
M<Z=;[Y6;/3%;_P ([7Q+IMW'!>V_EP+C^(_X5[QM!Z@'\* H'0 ?A6M";HP<
M-T372K--Z,9"S-&"W6I***D%HCSCXK:'=ZMHEQ%;1[W;H*\4^'/PYUW3?$%K
M+/:[$7J>?4>U?6. >HI-BC^$?E1AO]F<G'6Y=:7MHJ#Z$5HA2%0>N*GHHH;N
M[F<8\JL%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jun. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001069258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">KRATOS DEFENSE & SECURITY SOLUTIONS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-277222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Jun. 26, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">14,935,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">38.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 575,000,002.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 88,032.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">1a. Includes 1,948,052 shares of common stock of the Registrant issuable upon exercise of the underwriters' option to purchase additional shares of common stock.

1b. The filing fee is calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended (the "Act"). In accordance with Rule 456(b) and Rule 457(r) of the Act, the Registrant initially deferred payment of all of the registration fees for Registration Statement No. 333-277222 filed on February 21, 2024.

1c. This registration fee table shall be deemed to update the "Calculation of Filing Fee Table" in the Company's Registration Statement on Form S-3 (File No. 333-277222) in accordance with Rule 456(b) and Rule 457(r) under the Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jun. 26, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 575,000,002.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">88,032.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 88,032.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="21">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 21,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001069258-25-000040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001069258-25-000040-xbrl.zip
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M_!$K-Z@YT2USFL ]WYP:!L.;YRBB+>FM\T9;^=%T (6LR.OA8 J )7K[#-Q
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M^-Q5I'+"WVM:AFDFFA%Z3?PE,/K_ 5!+ 0(4 Q0    ( )"3VEH'(\L4H0H
M %9&   0              "  0    !E>&9I;&EN9V9E97,N:'1M4$L%!@
0   !  $ /@   ,\*      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069258</identifier>
        </entity>
        <period>
            <startDate>2025-06-26</startDate>
            <endDate>2025-06-26</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069258</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-26</startDate>
            <endDate>2025-06-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-207">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-208">424B5</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-209">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="rc" id="ixv-210">333-277222</ffd:RegnFileNb>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-211">0001069258</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-212">KRATOS DEFENSE &amp; SECURITY SOLUTIONS, INC.</dei:EntityRegistrantName>
    <ffd:FnlPrspctsFlg contextRef="rc" id="ixv-213">false</ffd:FnlPrspctsFlg>
    <ffd:FormTp contextRef="rc" id="ixv-238">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-239">KRATOS DEFENSE &amp; SECURITY SOLUTIONS, INC.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-240">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-241">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-242">Common Stock, $0.001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-243">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-244"
      unitRef="Shares">14935065</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-245"
      unitRef="USD">38.50</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-246"
      unitRef="USD">575000002.50</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-247"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-248"
      unitRef="USD">88032.50</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-249" unitRef="USD">575000002.50</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-250" unitRef="USD">88032.50</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-251" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-252" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-253" unitRef="USD">88032.50</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-254">1a. Includes 1,948,052 shares of common stock of the Registrant issuable upon exercise of the underwriters' option to purchase additional shares of common stock.

1b. The filing fee is calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended (the "Act"). In accordance with Rule 456(b) and Rule 457(r) of the Act, the Registrant initially deferred payment of all of the registration fees for Registration Statement No. 333-277222 filed on February 21, 2024.

1c. This registration fee table shall be deemed to update the "Calculation of Filing Fee Table" in the Company's Registration Statement on Form S-3 (File No. 333-277222) in accordance with Rule 456(b) and Rule 457(r) under the Act.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
